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Utilization and Outcomes of Exposure Therapy in Child and Adolescent Usual Care 
ABSTRACT 
 Exposure-based therapy approaches are efficacious for a range of youth anxiety, 
avoidance, and related problems.  However, exposure is frequently underused and there is 
little or no difference in effectiveness between exposure-based interventions and usual 
care on anxiety-related problems.  The present study examined the rate and patterns of 
exposure therapy use and the relationship between exposure use and treatment progress in 
youth receiving public mental health services in Hawai‘i from 2006-2015.  Therapist-
reported treatment characteristics, therapist and client variables, and other outcome data 
were examined using two cross-classification modeling approaches.  First, a cross-
classified logistic regression determined predictors of exposure use in anxiety-related 
treatment cases.  A second cross-classified regression model then examined whether 
anxiety-related treatment progress was predicted by amount of exposure use after 
controlling for other variables.  Of 6,616 treatment episodes in which an anxiety-related 
problem was addressed at any time during treatment, exposure was used in only 1,372 
(20.7%).  Exposure was more likely to be used when fewer externalizing problems were 
also targeted, in more recent years, and when anxiety seemed a more salient problem 
(such as when a youth experienced increased emotional impairment, when multiple 
anxiety-related problems were targeted within an episode, and when a youth carried an 
anxiety-related diagnosis).  Contrary to expectations, therapist doctorate degree was not 
associated with exposure use.  Four or more months of exposure in an episode was 
associated with higher anxiety-related treatment progress.  This association occurred 
primarily in the community-based residential treatment setting, and persisted after 
v 
 
accounting for other significant predictors of improved anxiety-related outcomes (longer 
episodes, greater number of other practices, fewer treatment months in which 
externalizing problems were targeted, and several variables indicative of lower 
impairment).  These findings suggest that while usual care therapists underutilize 
exposure, conditions predicting its increased likelihood of use appear well-considered 
and appropriate.   Further, dissemination efforts have likely been helpful in increasing 
exposure utilization in this system of care.  However, any treatment improvement 
associated with exposure use appears contingent on a specific set of circumstances 
suggestive of sufficient duration of implementation and possibly when barriers to 
treatment success are attenuated.  Practice and future research implications are discussed. 
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CHAPTER 1. INTRODUCTION 
 Exposure therapy seeks to put anxious, avoidant, obsessive, and/or traumatized clients in 
proximity to feared stimuli in a repeated, structured, productive way to decrease fear, distress 
and/or impairment related to those stimuli (e.g., Bornheimer, 2014).  Exposure is deeply rooted 
in behavioral research on fear responses, which can be traced to seminal studies by Watson and 
Jones (e.g., Watson & Rayner, 1920; Jones, 1924).  While the famous work with little Albert 
has been the subject of controversy, the classic repeated pairing of a neutral stimulus (a white 
rat) with an aversive stimulus (a loud noise) in order to develop a conditioned fear in a one-
year-old boy is one of the earliest studies to suggest that fear can be learned via conditioning 
(Watson & Rayner, 1920; Harris, 1979).  Several years later, Jones seems to have been the first 
to apply this principle in a therapeutic context resembling exposure therapy.  She worked with 
toddlers with various phobias by gradually associating feared stimuli such as rats or rabbits with 
a positive stimulus (mealtime) until the fear subsided and the children were able to interact with 
the animals without distress (Jones, 1924). 
Mowrer expanded on these studies a decade later, providing further credence to the idea 
that fear is a conditioned as well as an instinctive response, through both rat and human 
experiments pairing aversive and neutral stimuli (e.g., Mowrer, 1939).  Using novel electric 
shock experiments, Mowrer (1939) concluded that anxiety1 is anticipatory in nature (as 
evidenced by subjects experiencing maximum physiological arousal prior to, and not during or 
after, the application of an electric shock), and serves as a conditioned reaction to pain.  Further, 
he established that anxiety serves the adaptive role of preventing painful stimuli from occurring 
                                                                 
1 While anxiety and fear have been differentiated on the grounds that fear has a consciously perceived 
and/or imminent object and anxiety does not (e.g., Barlow, 2000; Mowrer, 1939), these two terms will 
be used synonymously in the present study. 
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by promoting avoidance of such stimuli (Mowrer, 1939).  Other researchers have since further 
specified the adaptive nature of the fear system via the Yerkes-Dodson law, which indicates that 
appropriate levels of anxiety play a role in promoting adaptive functioning by heightening 
awareness and increasing vigilance, particularly with regard to new, novel, or complex tasks 
(Beidel & Alfano, 2011; Crespi, 1942). 
 While an adaptive level of anxiety can facilitate performance, excessive anxiety results 
in steady declines in adaptive functioning and increases in pathologically avoidant behavior 
(Crespi, 1942).  Lang (1968) first proposed a three-component model of anxiety that included 
physiological responses, behavioral responses, and cognitions (originally referred to as 
subjective distress), and noted that pathological anxiety can emerge within or across each of 
these domains.  Extreme physiological responses to fear in children include those that are both 
situational (e.g., headaches, stomachaches, sweating, shortness of breath), and persistent (e.g., 
decreased heart rate variability), and can manifest as both cause and/or effect of a fear response 
(e.g., Ginsburg, Riddle, & Davies, 2006; Monk et al., 2001).  Behavioral responses are typically 
framed within the context of reducing or avoiding distress related to a given fear, and can 
include overt and often oppositional avoidance (e.g., crying, tantrums, clinging to parents), 
more passive avoidance (e.g., refusing to speak in social situations; acting sick to avoid school), 
and repetitive and/or ritualized actions (e.g., checking, counting, or washing things ) to avoid or 
lessen distress (see Beidel & Alfano, 2011, for a review).   
Impairments in thinking are difficult to discern in children, given that many young 
children are unable to clearly articulate thoughts related to their fears. Nevertheless, excessive 
and pervasive worry about everyday events (e.g., performance on tests or safety of family 
members) or persistent, often unrealistic obsessive thoughts (e.g., “my heart will stop and I will 
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die”) have been found in older children and adolescents (Prins, 2001).  Some evidence has 
suggested that pathological anxiety is associated with attentional and interpretive biases (i.e., 
disproportionately attending to feared stimuli and associating threat with neutral stimuli; see 
Muris & Field, 2008, for a review) and consequent heightened fear-potentiated startle responses 
(Stein et al., 2010). 
Mental health problems that manifest in collections of symptoms such as those noted 
above have been categorized and labeled within the American Psychiatric Association (APA)’s 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5; APA, 2013).  These diagnoses 
have been refined over time, and currently include disorders that are directly related to fear and 
anxiety (e.g., generalized anxiety disorder, social anxiety disorder, specific phobias, panic 
disorder), as well as obsessive-compulsive disorder (OCD) and stress-related disorders (e.g., 
Post-Traumatic Stress Disorder or PTSD).  Such diagnoses can be seen in up to 15% of children 
and adolescents (e.g., Beidel & Alfano, 2011).  
Anxiety, obsessions/compulsions, and post-traumatic stress share important common 
features despite recently receiving separate chapters in DSM-5 (Friedman, Resick, Bryant, 
Strain, Horowitz, & Spiegel, 2011; Stein et al., 2010).   In addition to shared biological 
correlates (e.g., amygdala hyper-responsivity) and shared cognitive symptoms (e.g., pervasive 
worry), all of these disorders have been argued to share similar underlying processes (Barlow, 
2000; Friedman et al., 2011; Mowrer, 1960; Stein et al., 2010).  Mowrer (1960) defined a 
process he believed was common across anxiety problems in which a conditioned stimulus (e.g., 
thought, image, object) is paired with an aversive unconditioned stimulus and thereby elicits a 
conditioned response (i.e., fear, anxiety, or distress). Once the conditioned anxiety response is 
acquired, it serves as a discriminative stimulus that evokes avoidance, escape or otherwise 
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distress-reducing behaviors (i.e., compulsions), which are negatively reinforced by the reduction 
of anxiety (Mowrer, 1960).  However, more recent research has called the commonality of this 
process into question, given, for example, the difficulty in linking a clear process of stimulus 
conditioning to the diffuse and expansive anxiety of Generalized Anxiety Disorder.  Barlow’s 
Triple Vulnerability model instead suggests that early life experiences (e.g., modeling by early 
caregivers) and/or proximal learning (e.g., acute trauma) interact with biological factors (e.g., a 
genetic predisposition to behavioral inhibition) in the development of pathological anxiety 
(Barlow, 2000).  In this model, a classically-conditioned stimulus response is not necessary for 
the development of a disorder.  For example, an over-controlling family environment, in which 
a child experiences little personal control, might heighten individual feelings of perceived 
uncontrollability and subsequently produce non-specific fears across a variety of situations 
(Barlow, 2000).  As discussed below, the mechanism of exposure therapy fits either 
conceptualization of pathological anxiety, and has been used to address explicitly-defined 
impairing discriminant stimuli vis-a-vis Mowrer and broader locus-of-control liabilities vis-a-
vis Barlow. 
Exposure Therapy: Etiology, Modalities, and Rationale 
Etiology of exposure treatment.  Joseph Wolpe is regarded as the first to formulate a 
structured treatment protocol for anxiety based on the principles established by Watson, Jones, 
Mowrer, and others (e.g., Tryon, 2005). Via the process that eventually became known as 
systematic desensitization, Wolpe treated patients suffering from a range of neuroses and 
phobias by exposing them to a feared stimulus, triggering distress responses and then 
immediately guiding them through a process of progressive full-body relaxation (Wolpe, 1961).  
Wolpe believed that his success in treating these patients was driven by the process of 
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reciprocal inhibition, originally proposed by Sherrington (1908), by which two incompatible 
psychological states (i.e., anxiety and relaxation) cannot exist simultaneously.  He suggested 
that an inhibitory learning process occurs over multiple trials of associating relaxation with a 
feared stimulus, resulting in a replacement of the fear with a feeling of relaxation (Wolpe, 
1961).  While the inhibitory learning theory behind exposure has persisted over time, Wolpe’s 
proposed mechanism for facilitating that learning has not.  Contemporaries of Wolpe achieved 
similar successes by exposing phobic and anxious patients to feared stimuli without pairing with 
relaxation techniques (Tryon, 2005).  A literature review by Marks (1975) compiled more than a 
decade of this evidence and concluded that systematic desensitization was no more effective 
than exposure to anxiety- or fear-related stimuli, and in the process coined the term exposure 
therapy. 
Exposure modalities.  Specific exposure therapy processes and practices vary 
(Abramowitz, 1996; Marks, 1975; Tryon, 2005).  In his review of treatment studies, Marks 
noted that clients could be exposed to feared stimuli gradually (via the development of a fear 
hierarchy and systematic exposure to increasingly more challenging items within that hierarchy) 
or they could be flooded (i.e., exposed abruptly to highly-aversive stimuli until distress 
decreased; Marks, 1975).  Marks also noted that fears could be encountered imaginally (e.g., 
prolonged thought exercises) in-vivo (e.g., exposure to stimuli in the physical world), or 
interoceptively (e.g., instigating physical sensations such as hyperventilation), for long or short 
durations, and that these exercises could be therapist-facilitated or performed by patients outside 
of session (Marks, 1975).  Technological advances have further nuanced these variations: the 
imaginal/in-vivo distinction has been further enriched by virtual exposure performed through 
the use of computers with sophisticated multi-sensory interfaces designed to replicate real-
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world situations, and client-led exposure sessions in particular and anxiety treatment in general 
can now be facilitated by computer, without any in-person interactions with a therapist  (e.g., 
Khanna & Kendall, 2010; Krijn, Emmelkamp, Olafsson, & Biemond, 2004). 
Rationale for exposure and proposed mechanism of change.  Given the diverse 
assortment of exposure therapy modalities (e.g., Abramowitz, 1996; Khanna & Kendall, 2010; 
Krijn et al., 2004; Tryon, 2005), the question of whether there is a singular mechanism of 
change underlying these treatments arises.  Over the past two decades, strictly behavioral and 
strictly cognitive models explaining the principles behind exposure’s efficacy have been 
proposed.  Tryon (2005) offers a thorough review of both, with behavioral models including 
habituation (a decreased fear response due to repeated stimulation), extinction (e.g., the removal 
of the unconditioned stimulus for a phobic behavior), and counterconditioning (replacement of a 
pathological response with an adaptive response).  Cognitive models include self-efficacy 
(developing a positive view of one’s ability to cope), expectation (fostering the belief that one 
will successfully overcome anxiety), and cognitive restructuring (changing one’s perception of a 
phobic object/situation from one of danger to one of innocuousness; Tryon, 2005).  These 
narrow models have been rejected in favor of more comprehensive learning models 
incorporating many of their elements (e.g., Bouton, 1993; Craske, 2014; Rescorla & Wagner, 
1972; Tryon, 2005; Tryon & McKay, 2009).   
Unlike Wolpe’s systematic desensitization hypothesis that anxiety and fear can be 
inhibited by an incompatible replacement stimulus such as relaxation, Rescorla and Wagner 
(1972) theorized that the mechanism of exposure therapy is the violation of expectancy.  In this 
inhibitory learning model, exposure treatment creates a situation in which the feared 
consequence of an aversive stimulus does not occur, thus inhibiting previously-learned 
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maladaptive reactions and enabling new learning related to the aversive stimulus to commence 
(Craske, 2014).   Explained from the connectionist perspective, the therapist facilitates 
dissonance by encouraging the client to behave adaptively in response to an aversive stimulus 
(e.g., an anxious thought or a fear-inducing situation), and the learning process modifies 
synaptic weights (i.e., the influence of the firing of one neuron upon another) related to that 
stimulus (Tryon, 2005).  Additional exposure trials repeat this dissonance-
formation/consonance-seeking process, further strengthening new neural connections indicative 
of adaptive functioning (Tryon, 2005).  This new therapeutic conditioned stimulus (CS)-
unconditioned stimulus (US) relationship competes with, rather than replaces, the pathological 
CS-US relationship.  Accordingly, the permanence of this new learning is moderated by time 
and memory, and without continued and varied reinforcement of the conditioned stimulus, the 
response can revert to a maladaptive one (Bouton, 1993).  Some preliminary support for this 
theory has been found in neuroimaging studies in which glucose metabolic rates were found to 
decrease significantly for patients undergoing CBT therapy for OCD (Baxter et al., 1992; 
Schwartz, Stoessel, Baxter, Martin, & Phelps, 1996).  A meta-analysis of social phobia 
treatment studies and a recent study on exposure therapy for traumatized war veterans provide 
some additional support for the permanence principle of this theory, indicating that an increased 
number of exposure trials across a treatment episode was associated with enhanced outcomes 
(Crawford, Wolf, Kretzmer, Dillon, Thors, & Vanderploeg, 2017; Feske & Chambless, 1995).   
Craske and others have applied these principles to optimize exposure through 
maximizing the degree to which expectancy is violated (Craske, 2014).  Such optimization has 
included, among other strategies: choosing exercises that result in lengthier exposure to 
situations in which a feared consequence does not occur, thereby increasing the permanence of 
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the learning experience (Craske, 2014); pairing multiple fear-provoking stimuli in one exposure 
session to rapidly generalize the learning experience across domains (Culver, Vervliet, & 
Craske, 2015); removing safety signals and behaviors during exposure exercises to minimize 
distractors or interference to learning (Sloan & Telch, 2002), and avoiding engagement with 
anxious patients in cognitive coping talk prior to exposure to optimize the link between the 
feared stimulus and the absence of a feared consequence without introducing any stipulations or 
conditions to this relationship (Craske, 2014).  This latter strategy is also indirectly supported by 
a recent study of therapist practices indicating that pre-exposure preparation, which included 
elements of coping self-talk, did not contribute to enhanced exposure outcomes, while 
processing exposure tasks after they occurred (and thus potentially extending the dissonance-
formation process) resulted in improved outcomes (Tiwari, Kendall, Hoff, Harrison, & Fizur, 
2013).    
Efficacy of Exposure Therapy 
Beginning in the 1990s, psychologists turned considerable attention to developing 
treatments that could be tested and shown to be efficacious (i.e., superior to a control group in 
an experimental setting) in order to elucidate which interventions therapists should use to 
maximize beneficial outcomes (Chambless & Hollon, 1998).  One of the decisions made by 
those tasked with creating the benchmarks for identifying what were then called empirically-
supported treatments (ESTs) was that treatments must be manualized in order to achieve the 
highest level of empirical validation (American Psychological Association, 1995).  Promising 
individual therapeutic processes like exposure were thus grouped and ordered into cognitive-
behavioral treatment (CBT) packages such as Kendall’s popular and well-researched “The 
Coping Cat.”  This therapy combines exposure with psycho-education, coping skill 
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development, and self-evaluation, among other elements, into a comprehensive anxiety 
treatment program (Kendall, 1994).  A possibly unintended consequence of the decision for the 
manualization criteria was the decline in research on individual practice elements such as 
exposure alone, calling into question what, if any, practices within a manual serve as the 
“specific ingredients” to affect positive change (e.g., Ahn & Wampold, 2001, p.251).  While 
there has been a reconsideration of specific practice elements, or modules, embedded in 
empirically-supported treatment manuals (e.g., Chorpita, Daleiden & Weisz, 2005), the majority 
of anxiety treatment efficacy studies have not examined exposure by itself (Abramowitz, 
Deacon, & Whiteside, 2012).  Therefore, in the following discussion of the efficacy of exposure 
treatment, exposure-only interventions will be highlighted, and manualized cognitive behavior 
therapy interventions that include exposure will be discussed by default.  Where no conclusive 
research focusing on children and adolescents exists, adult treatment literature will be discussed. 
Given that treatments are typically sorted by the diagnoses they address in the research 
literature, this discussion will be organized as such. 
Specific Phobias.  Perhaps because of their straightforward presentation, as well as their 
long history of psychological examination, specific phobias have received the most long-
standing experimental research attention of all the child anxiety disorders.  Much of this 
research predates the empirically-supported treatments movement, resulting in a number of 
studies examining exposure outside of the multi-component treatment manual context 
(Ollendick & King, 1998).  Ollendick & King (1998) deemed exposure a well-established, 
efficacious intervention strategy for phobic youth based on controlled trials in which graduated 
exposure (an intervention in which children engaged in gradually more difficult and repeated 
exposure to a feared stimulus and were reinforced for their successes) was superior to other 
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efficacious treatments (i.e., verbal coping skills and live modeling) across various specific 
phobias.  This status as a first-line treatment for specific child fears has persisted, and more 
recent single-case study research has suggested that exposure strategies are also effective in the 
treatment of phobias in the context of other severe comorbid conditions, including psychosis 
and autism (Nakamura, Schiffman, Lam, Becker, & Chorpita, 2006; Rapp, Vollmer, & 
Hovanetz, 2006). 
Generalized Anxiety Disorder, Social Phobia, and Separation Anxiety Disorder. 
Generalized anxiety disorder (GAD), social phobia (or social anxiety disorder), and separation 
anxiety disorder (SAD) were the original target diagnoses of The Coping Cat intervention 
(Kendall, 1994).  GAD is characterized as an excessive and persistent state of worry in one or 
more areas of an individual’s life; social phobia refers to pathological worry related to negative 
judgment, embarrassment, or ridicule in social settings; and SAD involves unrealistic worry 
accompanying separation from home or caregivers (Evans et al., 2005).  Randomized controlled 
trials (RCTs) have historically examined these three diagnoses together due in part to the 
similarity of their respective treatments, in which children receive extensive psychoeducation on 
the nature of fear and the skills used to cope with it and then apply such knowledge/skills as 
they practice fear-inducing situations (e.g., Barrett, 1998; Kendall, 1994; Kendall, Flannery-
Schroeder, Panichelli-Mindel, Southam-Gerow, Henin, & Warman, 1997).  This diagnostic 
grouping has been supported by the finding that improvement is typically consistent across 
diagnoses (Biedel & Alfano, 2011).  Across more than 15 trials, The Coping Cat and other 
analogous manualized treatments outperformed wait-list control conditions and resulted in an 
average of 65% of children no longer meeting diagnostic criteria for an anxiety disorder at the 
end of treatment (Kendall, Robin, Hedtke, Suveg, Flannery-Schroeder, & Gosch, 2005).  More 
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recently, this treatment protocol has been modified for computerized use, and an initial 
randomized controlled trial found computer-based CBT to be as effective as in-person CBT and 
superior to a control condition in reducing rates of anxiety disorder diagnosis (Khanna & 
Kendall, 2010).  Across all variations of The Coping Cat, exposure has been cited as a core 
component of the treatment package (Kendall et al., 2005).  While research isolating exposure 
treatment across these three disorders is limited, Nakamura, Pestle & Chorpita (2009) utilized a 
differential sequencing model across four pathologically anxious children diagnosed with some 
combination of these three diagnoses.  Each child received one of three treatment conditions 
(exposure-only, cognitive-only, and exposure plus cognitive treatment) in an order that varied 
for each participant.  Although parent reports of treatment progress were inconclusive, child-
reported anxiety levels decreased significantly during exposure treatment conditions but not 
during cognitive treatment conditions (Nakamura et al., 2009).  
Research examining exposure therapy separately for GAD, SAD, or social phobia 
among children and adolescents is limited.  Among these diagnoses, social phobia treatment has 
received the most attention (Beidel & Alfano, 2011).  Group cognitive behavioral interventions 
that emphasize exposure exercises have reduced social anxiety symptoms below diagnostic 
threshold for 45% to 81% of participants, with these rates beating those of control conditions 
across published studies (Hayward, Varady, Albano, Thienemann, Henderson, & Schatzberg, 
2000; Beidel, Turner, & Morris, 2000; Beidel, Turner, & Young, 2006).  Regarding socially 
phobic adults, a meta-analysis by Feske & Chambless (1995) indicated that exposure-only 
interventions were as effective as multi-component cognitive-behavioral interventions at 
reducing anxious and depressed symptoms among participants.  Ougrin’s (2011) meta-analysis 
indicated that social phobia was the only adult anxiety diagnosis (among social phobia, PTSD, 
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OCD, and panic disorder) for which exposure-only therapy resulted in superior outcomes 
compared to cognitive-only therapy. 
In the limited intervention research examining separation anxiety disorder, two 
treatments with a heavy focus on parent involvement (Parent-Child Interaction Therapy and a 
cognitive behavioral parent training protocol) have been found to be superior to control groups 
in reducing separation anxiety symptoms (Choate, Pincus, Eyeberg, & Barlow, 2005; Eisen, 
Raleigh, & Neuhoff, 2008).  One of these treatments explicitly trained parents in conducting 
both imaginal and in-vivo exposure exercises with their children, and both treatments included 
significant contingency management elements for parents, in which they were trained to avoid 
responding to reassurance-seeking behaviors from anxious children and to encourage and praise 
efforts at engaging in anxiety-provoking separation behaviors. 
The majority of children in early Coping Cat RCTs carried a primary diagnosis of GAD, 
and exposure has also been a component of several successful interventions studied on small 
samples of youth with GAD using time series designs (Clementi & Alfano, 2014; Eisen & 
Silverman, 1998; Kane & Kendall, 1989; Kendall, 1994, Kendall et al., 1997).  In the adult 
anxiety literature, exposure exercises for GAD have been specified as worry exposure (e.g., 
Hoyer, Beesdo, Gloster, Runge, Höfler, & Becker, 2009).  Such exercises might involve a client 
recording his/her description of a particular worry and listening to it repeatedly without 
engaging in any safety or reassurance-seeking behaviors (Ladouceur, Dugas, Freeston, Léger, 
Gagnon & Thibodeau, 2000).  Such worry exposure has been shown to be superior to a waitlist 
control and as effective as applied relaxation at reducing symptoms and impairment related to 
adult generalized anxiety (Hoyer et al., 2009). 
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Panic Disorder.  Panic disorder involves the repeated experience of intense fear, 
distress or foreboding due to spontaneous physiological symptoms such as accelerated heart 
rate, shortness of breath, choking sensations, dizziness, sweating, or a sense of 
depersonalization (Evans et al., 2005).  This fear often results in heightened anticipation of the 
onset of these symptoms in places from which escape is perceived as impossible, and a 
consequent avoidance of such places, also known as agoraphobia (Evans et al., 2005).  
Exposure treatments for panic disorder are typically both in vivo and interoceptive.  The low 
prevalence of panic disorder in youth has resulted in limited investigations of efficacious 
treatment, but a cognitive-behavioral treatment model adopted from the adult treatment research 
(i.e., Panic Control Treatment, or PCT) has been the subject of case studies and one controlled 
trial (Barlow & Sneider, 1983; Ollendick, 1995; Pincus, May, Whitton, Mattis, & Barlow, 
2010).  This intervention, which involves panic management procedures (e.g., breathing 
retraining), cognitive restructuring, and in vivo situational and interoceptive exposure exercises 
in and out of session, resulted in reduction of panic symptoms below clinical range for six out of 
seven adolescents examined in two case studies, and was compared favorably to a wait-list 
condition on self- and clinician-report measures of anxiety and panic (Pincus et al., 2010).  
While the specific effects of exposure have not been parsed out in such studies of adolescents, 
exposure-only interventions have been found to be beneficial among panic-disordered adults 
(e.g., Bouchard, Gauthier, Laberge, Fench, Pelletier, & Godbout, 1996; De Beurs, Van Balkom, 
Lange, Koele, & Van Dyck, 1995; Margraf & Schneider, 1991).  Although studies suggest 
equivalent treatment gains can also be made using cognitive interventions (Beck, Stanley, 
Baldwin, Deagle, & Averill, 1994; Bouchard et al., 1996; Margraf & Schneider, 1991), 
researchers have acknowledged that exposure exercises are difficult to completely exclude from 
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cognitive treatment, as cognitive restructuring typically involves testing unrealistic hypotheses 
(e.g., I will have a panic attack and die) related to feared situations, and such hypothesis testing 
necessarily involves exposure to the feared stimuli in question (e.g. Bouchard et al., 1996). 
Obsessive-Compulsive Disorder. Obsessive-compulsive disorder (OCD) involves 
recurrent obsessive thoughts and/or repetitive behaviors that an individual feels the urgent need 
to perform (Evans et al., 2005).  While compulsions (e.g., checking, cleaning, repeating, 
rearranging, or counting things) are common across youth with OCD, obsessional thoughts are 
more developed in adolescents, and frequently include contamination fears, concerns about 
illness or disease, and thoughts related to inflicting harm upon oneself or others, symmetry, 
religion, sex, and somatization (Beidel & Anthony, 2011).  Younger children are often unable to 
identify a clear obsessive thought related to a given compulsion (Swedo, Rapoport, Leonard, 
Lenane, & Cheslow, 1989).  Exposure-based treatment for child and adolescent OCD is based 
on an exposure/response prevention (ERP) intervention originally proposed by Meyer (1966), 
which includes elements of exposing an individual to a feared stimulus (e.g., touching a toilet 
seat) and preventing the individual’s compulsive response from occurring (e.g., washing hands; 
Abramowitz, 1996).  A randomized controlled trial comparing (a) CBT treatment that included 
elements of ERP, (b) sertraline medication (a commonly-prescribed selective serotonin reuptake 
inhibitor), (c) CBT + sertraline, and (d) a pill placebo found that all active treatments were more 
effective than placebo at improving OCD-related problems, and that CBT + sertraline resulted 
in the greatest symptom reductions (March et al., 2004).  CBT resulted in significantly higher 
rates of remission than sertraline (39% compared to 21%), and the authors concluded that OCD 
treatment in youth should begin with either CBT alone or a combination of CBT and sertraline 
(March et al., 2004).  Further, a recent meta-analysis of child OCD and anxiety treatment 
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compared ERP interventions for OCD to CBT interventions for child anxiety disorders and 
found the effect size of ERP on OCD (k=9, mean ES = 1.93) significantly higher than the effect 
size of CBT on other anxiety disorders (k=44, mean ES = 0.89; Ale, McCarthy, Rothschild, & 
Whiteside, 2015).  The authors suggested that this differential effect might be due to additional 
practice components within the CBT treatment protocol that might have diluted the effects of 
the exposure portion of the intervention (Ale et al., 2015).  A similar dilution effect was 
proposed in a review by Biedel & Alfano (2011) when they found the effect size of ERP (ES = 
1.60) compared favorably to CBT (ES = 0.97) for OCD across studies.  Although the conclusion 
that exposure and response prevention are the primary active ingredients in child OCD 
treatment remains plausible, numerous studies comparing exposure therapy to cognitive therapy 
for adults with OCD have typically not found differences between the two treatments (e.g., 
Emmelkamp, Visser, & Hoekstra, 1988; Van Oppen, De Haan, Van Balkom, Spinhoven, 
Hoogduin, & Van Dyck, 1995; Whittal, Thordarson, & McLean, 2005). 
Post-Traumatic Stress Disorder.  Post-traumatic stress disorder (PTSD) is unique 
among the diagnoses mentioned above in that it requires a significant stressor to precede the 
onset of pathological anxiety or distress (Evans et al., 2005).  To qualify for a PTSD diagnosis, 
an individual must either experience or witness an event/events involving actual or threatened 
death, serious injury, or compromised physical integrity of the individual or those witnessed.  
The individual consequently suffers a collection of persisting symptoms, including re-
experiencing the event, avoidance of stimuli associated with the event, negative changes in 
cognition or mood, hyperarousal, and/or depersonalization (Beidel & Alfano, 2011).  Such 
trauma can take the form of one isolated event or repeated, cumulative stressors, known as 
complex or Type II trauma (APA, 2013; Beidel & Alfano, 2011).  The heterogeneity of the 
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types of traumatic experiences children can experience (sexual assault, natural disasters, car 
accidents, etc.) has resulted in difficulty establishing consistently efficacious treatments for 
PTSD.  Randomized treatment trials targeting Type II trauma (i.e., repeated sexual abuse) have 
indicated that trauma-focused cognitive-behavioral therapy (TF-CBT) is superior to 
nondirective supportive therapy and child-centered therapy (Cohen, Deblinger, Mannarino, & 
Steer, 2004; Cohen, Mannarino, & Knudsen, 2005).  TF-CBT has received the highest 
classification of empirical support (“well-established”) for complex traumatic stress as a result 
(Chaffin & Friedrich, 2004; Chambless & Hollon, 1998).  Studies focusing on single traumatic 
events have also begun to emerge indicating that similar interventions are efficacious at 
reducing PTSD symptoms, with one of these studies comparing CBT favorably to a wait-list 
control (Smith, Yule, Perrin, Tranah, Dalgleish, & Clark, 2007) and another finding CBT and a 
meditation/relaxation intervention resulted in similarly beneficial outcomes (Catani, Schauer, 
Elbert, Missmahl, Bette, & Neuner, 2009).  Notably, all TF-CBT and CBT interventions under 
examination included a significant exposure component, which consisted of careful revisiting of 
a traumatic event via narratives, drawings, and imaginal or in-vivo methods to reduce distress 
related to the event (often referred to as prolonged exposure; Beidel & Alfano, 2011).  Among 
adults with PTSD, some evidence has suggested that exposure-only therapy results in equivalent 
symptom reduction rates compared to CBT (Paunovic & Öst, 2001), and another study 
indicated that exposure was superior to both relaxation training and eye movement 
desensitization and reprocessing (EMDR) therapy (Taylor, Thordarson, Maxfield, Fedoroff, 
Lovell, & Ogrodniczuk, 2003).  Recent work has also indicated that prolonged exposure was 
associated with large declines in PTSD symptoms for war veterans suffering a comorbid 
traumatic brain injury, and that this effect was enhanced by increasing the number of prolonged 
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exposure sessions a client received (Crawford et al., 2017).  However, as with OCD, studies 
have not indicated discernable differences when comparing imaginal exposure treatment to 
cognitive therapy in adults (e.g., Marks, Lovell, Noshirvani, Livanou, & Thrasher, 1998). 
Distillation and modularization of treatment for anxiety disorders.  A limitation of 
manualized treatments is that they discourage the investigation of specific change processes 
given their packaging of multiple therapeutic elements into a single intervention.  Chorpita, 
Daleiden, & Weisz (2005) have worked to address this concern using a distillation and 
matching model, an empirical approach to summarize specific treatment technique profiles 
described in various manualized treatments.  Originally aggregating information across 49 
successful treatment trials, the researchers created frequency counts of the relative occurrence of 
more molecular treatment techniques or practice elements (e.g., exposure, time-out, 
psychoeducation, etc.), as well as the circumstances in which these techniques were applied 
(e.g., the age and ethnicity of children who had been successfully treated in a given study), 
creating the foundation for a modularized approach to CBT delivery.  Modularized CBT allows 
for individual therapeutic practices to be thoughtfully assembled during a treatment episode 
based on a decision-making algorithm designed to better match and adapt to client needs and to 
address interference and barriers as they arise (Chorpita, Taylor, Francis, Moffitt, & Austin, 
2004).  Apart from such practical enhancements related to CBT delivery, an additional benefit 
of this work has been that it has allowed for renewed examination of individual therapeutic 
practice elements.  Perhaps most relevant to the current discussion, an updated summary by 
Chorpita & Daleiden (2009) expanded the number of treatment studies used to inform their 
distillation and matching model from 49 to 322.  This analysis indicated that exposure therapy 
was the single most common practice element within the empirically-tested interventions for 
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childhood anxiety and trauma-related problems, occurring in 80% and 91% (respectively) of all 
successful interventions studied for these problem areas (Chorpita et al., 2009). 
A recent study examined anxiety treatment for youth with a variety of anxiety disorders 
by comparing modularized CBT to The Coping Cat manualized intervention.  Researchers 
found that children who received exposure earlier via the modularized treatment (i.e., beginning 
exposure treatment at an average of session 2, compared to session 7 as prescribed in the 
manualized intervention) required fewer treatment sessions to achieve treatment gains 
equivalent to those made via the manualized treatment (Gryczkowski, Tiede, Dammann,  
Jacobsen, Hale, & Whiteside, 2012).  The researchers concluded that prioritizing exposure 
earlier in anxiety treatment could result in shorter treatment episodes.  In an earlier study, 
Chorpita and colleagues (2004) utilized modular CBT across eleven anxious youth in a multiple 
baseline design, and found that all subjects who completed treatment (n = 7) neither met criteria 
for their primary diagnosis at the end of treatment nor at 6-month follow up.  The researchers 
attributed this success to the flexibility inherent in modularized CBT, via which practice 
elements that fit an individual client’s circumstances could be delivered as needed (e.g., rewards 
for increasing at-home compliance or cognitive therapy for depressive symptoms; Chorpita et 
al, 2004). These and other intervention studies previously discussed (e.g., Nakamura et al., 
2006) suggest that modularized CBT offers a promising opportunity to examine the active 
components of efficacious treatment in general and exposure in particular. 
Taken together, the various studies described above have indicated that exposure therapy 
is equivalent or superior to other anxiety treatments across numerous diagnoses when examined 
as a stand-alone intervention (e.g., Ollendick & King, 1998), and that exposure is the most 
common component of empirically-supported manualized child anxiety treatment protocols 
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(Chorpita & Daleiden, 2009).   While promising, it is important to note that these results are 
based on efficacy studies, in which researchers have exerted considerable control over youth 
and therapist selection, treatment settings and modalities, and study conditions, and the active 
treatment is often compared to presumably inactive control conditions (Weisz & Kazdin, 2010). 
Effectiveness of Exposure Therapy 
In intervention science terminology, efficacy is not equivalent to effectiveness.  
Effectiveness research examines psychological interventions tested on representative samples of 
community-referred youth treated by practitioners in clinical service settings, particularly 
compared to the typical services youth receive (Weisz & Kazdin, 2010).  While effectiveness 
was an initial focus of the American Psychological Association’s task force in its strategy to 
determine empirically-supported interventions (American Psychological Association, 1995), 
explorations of treatment efficacy have been much more common than effectiveness studies 
over the past two decades (e.g. Chorpita & Daleiden, 2014).  An understanding of the state of 
the research on exposure’s effectiveness is critical to the relevance of the current study’s aims. 
One promising means to measure treatment effectiveness is by employing an efficacious 
treatment within a community mental health setting and comparing it to the typical services 
offered in that setting, often referred to as usual care or treatment-as-usual (Southam-Gerow, 
Weisz, Chu, McLeod, Gordis, Connor-Smith, 2010).  A limited number of such examinations 
related to child anxiety have emerged in the last decade.  In one of the earliest, CBT and 
treatment-as-usual (TAU) were both associated with improvement in generalized anxiety, social 
anxiety, and/or phobias, with no significant differences between the two groups (Barrington, 
Prior, Richardson, & Allen, 2005).  A follow up study by Southam-Gerow et al. (2010) again 
found no significant differences between the two treatments.  Importantly, success rates for both 
20 
 
groups as measured by percentage of children who no longer met diagnostic criteria at treatment 
end were slightly better than those found in comparable CBT efficacy studies’ treatment 
conditions (74% of usual care group; 67% of CBT treatment group; compared to a mean of 65% 
across efficacy studies as reported in Kendall et al., 2005).  As a partial explanation for the 
findings, the authors noted that only 59% of therapists in the CBT treatment group employed 
exposure practices and TAU therapists delivered substantially more supplemental services (e.g., 
additional therapy, group therapy) compared to the CBT group (Southam-Gerow et al., 2010).  
While this might explain the failure to find differences between the two effectiveness 
conditions, it does not address why the overall improvement rates of both TAU and CBT were 
similar to those found for CBT in efficacy studies.  
Altering the context of services to inner-city schools, Ginsburg, Becker, Drazdowski, & 
Tein (2012) found that usual care services delivered by community clinicians were equivalent to 
CBT (delivered by the same clinicians) in reducing child anxiety symptoms, improving global 
functioning, and diagnosis remission rates at 1-month follow-up, which were slightly less than 
those found in comparable efficacy studies (57% for TAU, 43% for CBT, compared to 65% 
across efficacy studies as in Kendall et al., 2005).  The authors noted that these comparable 
improvement rates might be attributable to TAU therapists’ relatively high ratings on measures 
of their adherence to certain elements of CBT processes, including agenda-setting and 
homework (though exposure use in TAU was not discussed; Ginsburg et al., 2010).  Contrary to 
these findings, a recent study by Storch and colleagues (2013) found that CBT was superior to 
treatment-as-usual (TAU) for treating anxiety disorders in children with autism, with 38% of 
children achieving anxiety-related diagnostic remission in CBT compared to 5% in the TAU 
condition.  However, the authors noted that their TAU condition was “designed to reflect the 
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typical community treatment services that could be received by children” (Storch et al., 2013, p. 
136).  As such, participants were simply offered the opportunity to initiate or continue receiving 
interventions of their choosing without influence by the study authors.  Fewer than half 
participated in psychotherapy, and this might have contributed to poor results (Storch et al., 
2013).  Similarly, Chiu and colleagues implemented a modularized anxiety treatment program 
in a school setting and found that the treated group improved substantially more on a measure of 
global improvement compared to a waitlist control (Chiu et al., 2013).  The considerable 
variability of the control conditions in general and TAU in particular for these effectiveness 
studies (and the lack of careful documentation of TAU conditions in effectiveness studies more 
broadly) is an issue that has received recent concern (Kazdin, 2015).  Thorough consideration of 
the characteristics of usual care is essential, both to increase the interpretability and 
generalizability of effectiveness study findings and to better understand a treatment modality 
that frequently compares favorably to more structured evidence-based treatments. 
There are no effectiveness studies that compare exposure therapy to other treatments 
outside of the manualized context, although recent studies by Weisz, Chorpita, and colleagues 
have suggested that delivering CBT in the more flexible modularized context discussed above 
results in enhanced treatment effects across a range of youth problem areas compared to both 
manualized CBT and TAU (Chorpita et al., 2013; Weisz et al., 2012).  Examining multiple 
problem areas together (i.e., depression, anxiety, and conduct problems), the researchers found 
that indices of externalizing, internalizing, and total problems decreased significantly more and 
more quickly in the modularized treatment condition than in either the manualized or TAU 
conditions immediately after follow up (with no difference between the manualized CBT and 
TAU groups), and that significant differences remained between the modularized treatment 
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condition and TAU upon two-year follow-up (Chorpita et al., 2013; Weisz et al., 2011).  
Though anxiety treatment (and thus exposure) was not examined separately from treatment for 
depression and conduct problems in this study, Gryczkowski and colleagues’ (2012) 
aforementioned modularized anxiety treatment design, which employed exposure earlier in 
treatment than the manualized intervention and resulted in faster progress, suggests that the 
increased flexibility inherent in modular approaches has the potential to affect anxiety outcomes 
in particular. 
Effectiveness research related to youth anxiety treatment in general and exposure in 
particular is in its infancy.  The limited effectiveness studies that have utilized a usual care 
treatment comparison group have not disentangled exposure from multi-practice treatment 
manuals to determine its discrete effect on anxiety problems.  Further, while usual care has 
resulted in equivalent or even slightly (though non-significantly) better outcomes than 
comparison CBT interventions for anxiety problems, no effectiveness study has examined the 
extent to which youth TAU therapists utilized exposure therapy, with multiple studies explicitly 
instructing TAU therapists not to engage in CBT interventions, including exposure (Ginsburg et 
al., 2010; Southam-Gerow et al., 2010).  At the least, such constraints limit the ability to 
accurately understand usual care therapist behaviors, and at worst might result in the artificial 
diminishing of the effects of treatment-as-usual services.  Finally, the effectiveness of exposure-
based interventions for youth has been tested entirely in outpatient settings (e.g., school mental 
health, university clinics).  While exposure-focused CBT interventions employed in residential 
facilities have been associated with symptom reduction for youth with OCD and trauma, such 
interventions have not been compared to residential usual care that does not include exposure 
(e.g., Cohen, Mannarino, Jankowski, Rosenberg, Kodya, & Wolford, 2016; Leonard et al., 
23 
 
2016).  There is a similar absence of data comparing exposure use to other interventions in other 
levels-of-care such as family therapy, therapeutic foster care, and inpatient hospital care.  Much 
remains to be learned about the utilization and potential effect of exposure in the context of 
typical service settings. 
The Underutilization of Exposure Interventions 
 Despite the demonstrated efficacy of exposure and interventions that include exposure 
for anxiety, phobias, trauma, and obsessive-compulsive problems, exposure treatments have 
been underused.  In a review of PTSD treatment delivered to over 4,000 veterans, researchers 
found that exposure therapy was used in only 20% of cases, and that the comparable usage rate 
was only 58% among 11 PTSD therapists nationally recognized for their expertise in exposure 
treatment (Foy, Kagan, McDermott, Leskin, Sipprelle, & Paz, 1996;  Litz, Blake, Gerardi, & 
Keane, 1990).  On more recent questionnaires related to exposure for PTSD, non-CBT trained 
and CBT-trained therapists retrospectively reported low lifetime use of exposure therapy (17% 
and 66%, respectively), and trained CBT therapists reported using exposure in only 
approximately one half of their PTSD cases (Becker, Zayfert, & Anderson, 2004).  In a recent 
follow-up study examining therapists’ use of different treatment practices two years after 
receiving specialized CBT training, child and adolescent therapists reported that exposure was 
their least-used intervention strategy for anxiety problems, reporting utilization in only 35% of 
cases (Chu, Talbott Crocco, Arnold, Brown, Southam-Gerow, & Weisz, 2015).  A preliminary 
analysis of the system of care currently under study indicated that therapists endorsed using 
exposure in only 11% of initial treatment episodes of child and adolescent cases that included 
treatment targets of anxiety, trauma, avoidance, phobias, or shyness (Milette-Winfree, Okado, 
Mueller, Higa-McMillan, & Nakamura, 2015).  Finally, as noted above, the one existing 
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controlled effectiveness trial that examined therapists’ usage rates of exposure in a manualized 
anxiety treatment context found that exposure interventions were used in only 59% of cases 
(Southam-Gerow et al., 2010).   
There are a number of potential explanations for this underutilization.  First, researchers 
have noted that exposure can be a difficult and resource-intensive intervention, often requiring 
implementation beyond the typical treatment context (e.g., outside of a clinic office and/or for a 
duration longer than a standard psychotherapy session, Chu et al., 2015; Cloitre, 2011; Becker 
et al., 2004).  Second, some PTSD therapists have limited familiarity with exposure as an 
intervention strategy (Becker et al, 2004).  Third, even among those familiar with exposure, 
therapists often report concerns related to treatment delivery (Becker et al, 2004; Boudewyns & 
Shipley, 2012).  Such concerns are typically related to perceived client discomfort that could 
lead to disengagement or retraumatization, as well as therapist discomfort with administering 
exposure and/or fear of malpractice litigation (Becker et al., 2004; Boudewyns & Shipley, 2012; 
Hembree & Cahill, 2007; Kovacs, 1996).   Schare & Wyatt (2013) coined the term 
“exposaphobia” (p. 243) to describe this phenomenon, noting that empirical research has not 
supported therapists’ misgivings about exposure treatment and therefore this underuse is at least 
in part due to the therapist’s own anxiety.  Regarding therapist demographic variables, survey 
data indicate that women and non-Ph.D.-level therapists use exposure therapy for adults less 
than men and Ph.Ds. (van Minnen, Hendriks, & Olff, 2010; Whiteside, S. P., Deacon, B. J., 
Benito, K., & Stewart, E., 2016). Therapists who are women, older, and have a training degree 
other than a Ph.D. also report more negative impressions of exposure therapy (Deacon et al., 
2013).  More broadly, the lack of specific training in the use of evidence-based practices, the 
impression of treatment manuals as being too rigid to apply to a given clinician’s diverse client 
25 
 
population, and the belief that such treatments require too much time, money, or support to 
implement have all been associated with lower rates of evidence-based practice (EBP) adoption 
(see Nakamura, Higa-McMillan, Okamura, & Shimabukuro, 2011 for a review).  A recent study 
suggests that these concerns have affected exposure use specifically, indicating that therapists 
who endorsed greater openness to evidence-based practices were more likely to utilize exposure 
(Becker-Haimes, Okamura, Wolk, Rubin, Evans, & Beidas, 2017).    
The presence of comorbid psychopathology that can be prioritized in treatment over 
anxiety symptoms may also play a role in a therapist’s limited use of exposure therapy (Milette-
Winfree & Mueller, 2017).  Comorbidity in this case refers to the existence of both internalizing 
(e.g., anxiety, depression, or somatic problems) and externalizing (e.g., disruptive behavior, 
hyperactivity problems) pathology in a given youth (e.g., Costello, Mustillo, Erkanli, Keeler, & 
Angold, 2003).  Research has frequently suggested that when approached separately, 
externalizing problems are referred for treatment at disproportionate ly higher rates than 
internalizing problems (Angold, Costello, & Erkanli, 1999; Bradshaw, Buckley, & Ialongo, 
2008; Costello & Janizewski, 1990; Goodman, Lahey, Fielding, Dulcan, & Regier, 1997).  A 
recent study expanded on these findings, indicating that when child and adolescent therapists 
are confronted with youth who have received comorbid internalizing (e.g., anxiety) and 
externalizing (e.g., disruptive behavior) diagnoses, they disproportionately target externalizing 
problems in treatment (Milette-Winfree & Mueller, 2017).  While these findings relate to the 
problems on which therapists focus rather than the practices they use, inferences about 
intervention choices can be hypothesized.  If anxiety is rarely identified, or identified as only 
one of many other more pressing treatment targets in comorbid cases, the utilization of exposure 
to treat it is likely to be low.  
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 Given the infrequent use of exposure in community treatment, little is known about the 
quality of exposure treatments delivered in this setting.  Previous research related to community 
therapists’ patterns of service delivery has only cursorily examined exposure treatment, and the 
results of existing studies have not been encouraging.  For example, Borntrager, Chorpita, 
Orimoto, Love, & Mueller (2013) examined community therapists’ reports of practice elements 
(PEs) used in treatment.  These reports were compared to coders’ evaluations of the 
extensiveness of use of a given PE in the same set of recorded sessions (0=no explicit mention 
of the PE; 1= a fleeting action or mention related to the PE; 2= a brief but explicit discussion of 
the PE; 3= explicit discussion or behavior reflecting the PE; Borntrager, 2013).  The researchers 
found that while therapists’ reports aligned closely with session coders’ counts of PEs, in order 
for this alignment to occur, coders had to lower the threshold for what counted as a particular 
practice, given that clinicians commonly endorsed practices that examiners classified as a 
“brief/fleeting mention or incomplete execution of PEs” (p. 378).  Notably, exposure was one of 
the practices under study (though it was only endorsed 8 times across all coded sessions) and 
achieved an average rating of 1.02 on the 0 to 3 extensiveness scale (Borntrager et al., 2013).  
Similarly, in a study that video recorded 96 usual care therapists delivering evidence-based 
practices for disruptive behavior, researchers found that therapists commonly utilized some 
EBPs (e.g., problem solving, positive reinforcement, and psychoeducation) and not others (e.g., 
homework and role playing), but that practices were typically delivered with low duration and 
low thoroughness (Garland, Brookman-Frazee, Hurlburt, Accurso, Zoffnes, & Haine-Schlagel, 
2010).  Taken together, these studies provide preliminary evidence of usual care therapists’ low-
fidelity and likely low-frequency or low-intensity delivery of evidence-based practices, 
including exposure, across multiple community health settings. 
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Dissemination and implementation research has emerged in the last decade delineating 
best practices for promoting high-fidelity use of evidence-based practices in general, such as 
offering dynamic and versatile training programs, monitoring therapists regularly for adherence, 
and enlisting key stakeholders to promote EBPs, among other strategies (e.g., Beidas & 
Kendall, 2010; Becker, Becker, & Ginsburg, 2012; Nakamura  et al., 2014).  Becker et al. 
(2012) analyzed school therapists’ session content for anxiety problems after they received 
intensive 2-day workshops on modularized CBT and found that therapists utilized exposure in 
100% of cases under study.  Though only a small number of cases were studied (n = 16), such 
results are encouraging in their indication that therapists’ patterns of exposure use may be 
amenable to change and that use of EBPs might be gradually increasing in recent years.  
Notably, considerable resources have been allocated to the dissemination and implementation of 
EBPs (e.g., training and outreach initiatives, performance feedback systems development, and 
consumer education efforts) in the system of care under study, offering an opportunity to 
determine whether exposure use has increased over the duration of these efforts (Nakamura et 
al., 2014).   
Summary of the Current State of Exposure Research 
Researchers have made in-roads regarding the processes underlying exposure therapy 
(e.g., Craske, 2014).  The efficacy of exposure and/or interventions that include exposure has 
been well-supported (e.g., Kendall et al., 2005).  Techniques have been proposed to optimize 
exposure’s impact, such as earlier and more frequent use in a treatment episode (e.g., Feske & 
Chambless, 1995; Gryczkowski et al., 2012).  However, the effectiveness of exposure, 
particularly as measured against treatment-as-usual, is not clear (e.g., Southam-Gerow, et al., 
2010).  Additionally, exposure is underused in mental health settings, and it is not known under 
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what circumstances or in what settings exposure is used by child/adolescent community 
therapists.  Finally, the relationship between exposure use and anxiety-related therapy outcomes 
in usual care is unknown. 
Study Aims 
The current study sought to examine the usage and associated outcomes of exposure 
therapy in a large usual care setting that provides multiple levels-of-care (e.g., in-home therapy, 
residential treatment, hospital services), with the hope of expanding the research on exposure 
treatment for anxiety and related problems in several important ways.  First, the study sought to 
evaluate and inform efforts to train and promote therapists’ use of exposure therapy by 
determining under what circumstances therapists were more and less likely to use it for anxiety-
related targets.  It was hypothesized that increased likelihood of exposure use would be 
associated with more recent treatment end dates, given recent initiatives to disseminate 
evidence-based practices, both broadly and in the system of care under study.  It was also 
hypothesized that as the proportion of treatment months in which therapists targeted 
externalizing problems increased, the likelihood of using exposure would decrease.  Regarding 
therapist characteristics, it was hypothesized that doctorate-level training would be associated 
with increased likelihood of exposure use given aforementioned research indicating enhanced 
opinions and use of exposure associated with Ph.D. degree (notably, gender and age of therapist 
have been associated with exposure in previous research, but were not available in the present 
study).  These predictor variables were examined along with various covariates related to 
treatment episode (episode length, mean number of practices used per month, number and type 
of unique anxiety-related targets endorsed in treatment, current presence of an anxiety-related 
diagnosis), client (gender, age, race, number of previous treatment episodes, emotional 
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impairment at episode start), and provider agency (level-of-care) via a cross-classified logistical 
predictive model. 
After these patterns of use were determined, the study then sought to contribute to the 
effectiveness and usual care literature related to treatment outcomes associated with exposure 
use.  A measure of anxiety-related treatment progress was examined using a cross-classified 
predictive model.  A variable reflecting the months of exposure use in treatment was tested to 
determine whether amount of monthly exposure use predicted improved treatment progress 
after accounting for covariates related to treatment episode (episode length, treatment end date, 
proportions of episode in which anxiety problems and externalizing problems were a focus, 
mean number of practices other than exposure endorsed per month, presence of an anxiety-
related diagnosis), client (sex, age, race, number of previous treatment episodes, emotional 
impairment at onset of episode), therapist (highest degree earned), and service delivery agency 
(level-of-care).  The episode month in which exposure was first endorsed was also examined to 
determine whether this timing moderated the association between exposure use and treatment 
progress.  It was hypothesized that a greater number of months of exposure use would be 
associated with significantly higher final progress ratings on anxiety and related targets, and that 
the earlier onset of exposure use in treatment would enhance the relationship between exposure 
and maximum progress ratings.  Such results would provide new evidence suggesting exposure 
contributes to effective treatment for anxiety-related problems in usual care, and could 
additionally help to specify under what conditions exposure is maximally useful in order to 
inform community mental health practices.  
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CHAPTER 2. METHOD 
Study Setting 
 Within the Hawaii system of care, public mental health services are provided to youth 
and families through the Department of Education’s school-based programs and an additional 
array of services contracted by the Department of Health’s Child and Adolescent Mental Health 
Division (CAMHD, 2012).  Upon meeting eligibility for CAMHD services, youth and their 
families are assigned a care coordinator, who assists in the management, planning, and 
coordination of treatment (e.g., CAMHD, 2012).  Therapeutic services are contracted through 
various youth mental health provider agencies and include multiple levels-of-care, which range 
in intensity from least restrictive (i.e., outpatient and intensive in-home services) to most 
restrictive (i.e., a locked sexual offender program and locked residential hospitals; see Appendix 
A for a description).  Additional levels-of-care include two types of manualized family therapy, 
community-based foster care, group home care, residential treatment, and emergency services, 
among others.  Given the study’s purpose of examining exposure treatment as it is applied in 
routine treatment settings, the study sample included treatment episodes within all levels-of-
care. 
Numerous investigations have examined the effects of practice selection on treatment 
outcome within the CAMHD system (Denenny & Mueller, 2012; Love, 2014; Orimoto, 
Mueller, & Nakamura, 2013), although none have examined exposure therapy for anxiety-
related problems.  Such studies are made possible by unique data collection systems in place, 
which allow for an examination of treatment characteristics not typically available in large 
community mental health settings.  These data, collected using the Monthly Treatment Progress 
Summary (MTPS; see description below), include therapists’ self-reported practices on a 
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month-to-month basis, client demographics, and several metrics of improvement, including 
therapist-reported progress, functional impairment, and successful discharge (CAMHD, 2008).  
This system of care has the potential to provide insight into the evolution of therapists’ 
acceptance of evidence-based practices such as exposure given the EBP dissemination and 
implementation efforts described above (Nakamura et al, 2014).  Furthermore, the archival data 
that emerge from this system of care allow for the examination of specific therapist practices in 
a bona fide usual care setting.  For example, steps taken in previous studies to ensure that usual 
care therapists were not engaging in practices that were too similar to the CBT protocol under 
examination (e.g., Southam-Gerow et al., 2010) do not apply in this study.  The practice of 
exposure can be examined by isolating those treatment episodes in which it occurs without 
influencing the episodes to which they are being compared.  This is one of several of the 
concerns identified by Kazdin (2015) related to treatment-as-usual research that can be 
addressed using these data, as well as identifying important characteristics of TAU (e.g., goals 
of treatment) so that a clear distinction between exposure treatment and non-exposure treatment 
can be determined, and controlling for typically uncontrolled variables in EBP-TAU 
comparison studies such as treatment dosage.  
Participants 
 Youth participants.  Participant information was drawn from a large dataset that 
initially included 22,788 youth who had any recorded interaction with CAMHD from July 1, 
2001 through August 31, 2015 (including many youth who were registered but never received 
services or received services prior to the date range of the study, which was by necessity tied to 
the implementation of the MTPS).  Youth with no MTPS data were excluded, reducing the 
sample to 6,777 youth.  Youth were then removed who (a) had none of four anxiety-related 
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targets described below endorsed on any MTPS (new n = 4396; see Monthly Treatment 
Progress Summary and Data Analytic Strategy for details), (b) did not receive treatment during 
the date range of the study (new n = 3513), and (c) were missing all MTPS practice or treatment 
progress data for anxiety-related targets (see Data Preparation for more information).  This 
resulted in a final sample of 3,511 youth, ages 3 to 19 (with an average age of 13.7 years at the 
start of their first episode under study), receiving treatment within the CAMHD system of care 
between July 1, 2006 and August 31, 2015 (see Table 1).  Youth participants were 
predominately male (61.8%) and racially diverse (57% categorized as multi-racial).  The most 
common primary diagnoses youth received in their first episode were related to disruptive 
behavior (31.0%), anxiety/traumatic stress/obsessions/compulsions (14.4%), attention problems 
(14.4%) and depression (10.9%).  Change in diagnosis over time was addressed by examining 
diagnoses at the episode level in statistical analyses.  Secondary and tertiary diagnoses are also 
recorded in the dataset, and when considering these over time, 28.6% of youth under study had 
at least one anxiety-related diagnosis during at least one treatment episode within the study’s 
date range.  See Table 1 for frequencies of other primary diagnostic categories and other 
demographic information.  Youth had an average of 2.85 total treatment episodes.  Of these, an 
average of 1.88 episodes per youth included one or more anxiety-related target.  This resulted in 
a total of 6,616 treatment episodes that met criteria for the present study, with an average of 200 
days in length and 7.81 MTPSs per episode across levels-of-care (see Table 2).  Anxiety-related 
targets were endorsed at an average rate of 69% of treatment months within an episode, and a 
mean of 16.7 intervention practices were used each month.  Youth typically experienced 
moderate emotional impairment across episodes as reflected by a mean episode CAFAS 
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Mood/Emotions subscale score of 17.9 (See Child and Adolescent Functional Assessment Scale 
below). 
 Therapist participants. MTPS clinical data were provided by MTPS reporters 
(henceforth, defined as “therapists” or “clinicians”).  Available therapist descriptive data were 
limited, but as seen in Table 3, treatment was delivered by 655 therapists in the system of care, 
63 of whom were doctorate-level therapists.  Among these, 12 were Ph.D. clinical 
psychologists, 26 were Psy.D. clinical psychologists, 16 were M.D.s, and 9 had other doctorate 
degrees.  The remainder of service providers consisted of 351 masters-level clinicians in the 
fields of counseling, psychology, or marriage and family therapy, 159 masters of social work, 
41 clinicians with other masters degrees, 29 bachelors-level clinicians, 8 clinicians who finished 
high school and four whose degree could not be determined.  The credentialing database used 
for the present study did not include information regarding therapist age, gender, or ethnicity. 
Therapist characteristics were likely consistent with those noted in prior studies, which have 
reported CAMHD therapists as about 75% female, ethnically diverse, and having a mean age of 
around 40  years (Nakamura, Higa-McMillan, Okamura, & Shimabukuro, 2011; Orimoto, Higa-
McMillan, Mueller, & Daleiden, 2012).   
 Provider agency/level-of-care.  As seen in Table 4, services were provided by a total of 
83 different agencies.  These agencies were classified by differences in (a) the organization 
providing services (n = 16), (b) the island on which the agency was housed (n = 4), and (c) the 
type of service the agency provided (e.g., intensive in-home therapy, functional family therapy, 
hospital-based services) in order to capture maximum random variance across agencies.  Due to 
similarities among many of the 16 service classifications noted in the original dataset and to 
facilitate data analysis, these were condensed into nine categories of level-of-care in the 
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statistical models described below (see Appendix A for a description of services subsumed 
within each level-of-care).  Episodes most commonly fell under the intensive in-home (n = 
3083, 46.6%), therapeutic foster (n = 1028, 15.5%), community-based residential (n = 972, 
14.7%), and hospital-based (n = 517, 7.8%) levels-of-care (see Table 2).  
Measures 
Monthly Treatment Progress Summary (MTPS; CAMHD, 2005; Appendix B). The 
MTPS is a therapist report form designed to collect ongoing information on service formats, 
settings, service dates, treatment targets, practice elements, client progress ratings, medications 
and dosage, reason for discharge, and discharge living situation.  Each section of the MTPS has 
predefined responses and open-ended fields to provide therapists with the opportunity to write 
in their responses.  Since 2006, contracted therapists within CAMHD have been required to 
complete MTPSs each month for all youth in order to receive reimbursement for their services 
(Nakamura, Higa-McMillan, & Chorpita, 2012).  Due to this requirement, MTPS completion 
rates are very high (96.6%).  CAMHD has provided statewide trainings on using the MTPS and 
has created the Instructions and Codebook for Therapist Monthly Summaries, which is available 
to therapists online (see Appendix C; CAMHD, 2008).  
In the event that multiple therapists provide services for a client within the month 
reflected by the MTPS (mean clinicians per episode = 1.36), the therapist who is most familiar 
with the youth, family, and services provided during that month completes the MTPS after 
consulting with the other therapists and is linked to the “Clinician ID” on the form (CAMHD, 
2012).   A qualified supervisor then verifies the accuracy of the information, signs and dates the 
MTPS, and sends the form to the Care Coordinator by the fifth day of each month.  All 
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statewide MTPS data are entered into the Child and Adolescent Mental Health Management 
Information System (CAMHMIS) through standardized procedures at the various Family 
Guidance Centers.  The CAMHMIS is a data management system that is compliant with the 
standards set by the Health Insurance Portability and Accountability Act (HIPAA).  
Treatment targets and progress ratings.  On the MTPS, therapists are instructed to 
identify up to ten treatment targets addressed during the month, from a list of 48 predefined 
responses and two write-in fields.  They then assign progress ratings to each of the identified 
targets, based on the extent of progress achieved between the child’s baseline level of 
functioning and the goal for that target.  Progress ratings are ranked on a seven-point (0-6) scale 
with the following anchors: Deterioration (<0%), No Significant Change (0-10%), Minimal 
Improvement (11-30%), Some Improvement (31-50%), Moderate Improvement (51-70%), 
Significant Improvement (71-90%), and Complete Improvement (91-100%), with higher 
numbers indicating greater improvement.   
Prior research has found that treatment targets relate to diagnoses in a predictable 
manner (Daleiden, Lee, & Tolman, 2004).  In addition, Nakamura, Daleiden, and Mueller 
(2007) found that one-half to two-thirds of target selections were stable from intake to three, six 
and nine-months into treatment and Daleiden and colleagues (2004) found moderate treatment 
target stability from baseline to one-month (k = 0.66) and three-months (k = 0.52) into 
treatment.  Love, Okado, Orimoto, and Mueller (2016) conducted exploratory and confirmatory 
factor analyses of the treatment targets and found evidence for a five-factor structure 
corresponding to the areas of disinhibition, societal rules evasion, social engagement deficits, 
emotional distress, and management of biodevelopmental outcomes, and Milette-Winfree & 
Mueller (2017) used non-parametric tests to determine treatment targets associated with 
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externalizing and internalizing disorders, and found these targets were closely related to the 
respective problem areas within which they were categorized.   
With regard to progress ratings associated with these treatment targets, Nakamura et al. 
(2007) found significant correlations between progress ratings on MTPS forms completed by 
therapists and other measures of clinical functioning and improvement.  For example, compared 
with the Child and Adolescent Functional Assessment Scale (CAFAS; Hodges, 1994), where 
higher scores indicate more impairment, the MTPS progress ratings were significantly 
negatively correlated (r = -0.22 to -0.44) at one-, three-, and nine-month follow-ups.  Notably, 
the CAFAS is completed by administrative program staff and not by therapists.  These 
correlations provide evidence of convergent validity for the progress ratings on the MTPS.  
 Intervention strategies.  Each month, therapists are also instructed to indicate 
intervention strategies (i.e., practice elements or PEs) utilized with youth in the given MTPS 
month from a list of 63 predefined responses and three write-in options.  Daleiden et al. (2004) 
noted a moderate one-month (k = 0.65) and three-month (k = 0.5) stability of PE choice from 
the start of treatment.  An exploratory factor analysis of the PEs suggested a three-factor 
structure, including Behavioral Management (15 PEs), Cognitive/Self-Coping (19 PEs, with 
exposure falling within this category, factor loading = .55), and Family Interventions (13 PEs; 
Orimoto, Higa-McMillan, et al., 2012).  Factors were found to be correlated (r = 0.46-0.52) and 
to have adequate to good internal consistency (Orimoto, Higa-McMillan, et al., 2012).  
Additionally, the PEs have established adequate inter-rater reliability (intraclass correlations 
[ICCs] = 0.6 or higher for some PEs) and convergent validity with audio-recordings of 
treatment sessions rated and coded by independent observers (Borntrager et al., 2013; Daleiden 
et al., 2004).   
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Child and Adolescent Functional Assessment Scale (CAFAS; Hodges, 1994).  The 
CAFAS is a 200-item clinician measure that assesses youths’ level of functional impairment 
(see Appendix D).  Based on clinical interviews, case managers in CAMHD assign behavioral 
descriptions ordered by level of impairment within eight domains of functioning: School Role 
Performance, Home Role Performance, Community Role Performance, Behavior Toward 
Others, Mood/Emotions, Mood/Self-Harmful Behavior, Substance Use, and Thinking.  Scores 
for each subscale are calculated by scoring the highest level of impairment (i.e., severe = 30, 
moderate = 20, mild = 10, no/minimal = 0) endorsed within the respective domain.  Total scores 
are obtained by summing across the eight subscales.  Interpretation guidelines for the total score 
suggest: 0-10 = “None to minimal impairment”, 20-40 = “Likely can be treated on an outpatient 
basis”, 50-90 = “May need additional services beyond outpatient care”, 100-130 = “Likely 
needs care which is more intensive than outpatient and/or which includes multiple sources of 
supportive care”, and 140+ = “Likely needs intensive treatment, the form of which would be 
shaped by the presence of risk factors and the resources available within the family and the 
community.”  Internal consistency of the CAFAS across items has been determined as adequate 
(α = 0.73 to 0.78), with high inter-rater reliability across sites (intraclass correlations [ICCs] >= 
0.84; Hodges, 1995; Hodges & Wong, 1996).  Concurrent validity studies have found that 
CAFAS scores are valid proxies to estimate treatment change, and are related to severity of 
psychiatric diagnosis, intensity of care provided, restrictiveness of living settings, juvenile 
justice involvement, social relationship difficulties, school-related problems, and risk factors 
(Hodges & Gust, 1995; Mueller, Tolman, Higa-McMillan, & Daleiden, 2010; Nakamura et al., 
2007).  An exploratory factor analysis of the eight CAFAS subscales indicated a two-factor 
structure, with the Mood/Emotions, Mood/Self-Harmful Behavior, and Thinking subscales 
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grouped within an internalizing factor (factor loadings = .46-.58), and the remaining subscales 
grouped within an externalizing factor (factor loadings = .50-.75; Ebesutani, Francis, & 
Chorpita, 2008).  Of these subscale scores, the Mood/Emotions subscale is the most relevant to 
the present study, as it is the only subscale score that describes impairment specifically related 
to anxiety.  For example, a sample description of a CAFAS Mood/Emotions subscale score of 
30 is, “Fears, worries or anxieties result in poor attendance at school (i.e., absent for at least one 
day per week on average) or marked social withdrawal (will not leave the home to visit with 
friends)” (Hodges, 1994, p. 7). 
Procedures 
Data source. The Research Evaluation and Training Program (RET) within CAMHD 
provided a limited dataset with clinical and demographic data from CAMHMIS for the service 
period in question.  CAMHMIS maintains records on all CAMHD clients, consistent with 
CAMHD’s data storage procedures (CAMHD, 2012).  All therapist data were electronically 
extracted from the credentialing database that is developed and maintained by the Credentialing 
Office of CAMHD.  This database provided therapists’ education level and professional 
information (e.g., specialty).  
Human subjects considerations. Upon entry into CAMHD, the legal guardian of the 
youth receives a complete description of CAMHD’s privacy policies and signs the Notice of 
Privacy Practices consent form, which allows for the use of data for research purposes (see 
Appendix E).  This consent form adheres to the HIPAA and Family Educational Rights and 
Privacy Act standards. This study received exempt approval from University of Hawai‘i at 
Mānoa’s Institutional Review Board due to (a) the nature of this study being archival, (b) the 
fact that legal guardians of youth under study are required to sign the Notice of Privacy 
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Practices to receive services, and (c) the data-limited nature of the data (i.e., no directly 
identifiable client information).   
Data Analytic Strategy 
Selection of episodes based on anxiety-related targets/progress ratings and episode 
start date.  In the present study, the endorsement at any time during a treatment episode of any 
combination of six targets that were theoretically related to anxiety based on their definition in  
the codebook for using the MTPS (see Appendix C) and empirically related to internalizing 
problems was used as an initial episode inclusion criterion (Milette-Winfree & Mueller, 2017).  
These targets were: anxiety, avoidance, compulsive behavior, shyness, phobias/fears, and 
traumatic stress.  Two of these targets were removed from this inclusion criterion after 
preliminary analyses.  Compulsive behavior was omitted given its removal from a revised 
version of the MTPS in 2008 due to extremely low earlier endorsement rates (occurring in 10 of 
6656 episodes in the preliminary dataset; CAMHD, 2012).  Shyness was also removed due to 
somewhat low endorsement rates (occurring in 205 of 6656 episodes in the preliminary dataset) 
and lower bivariate correlations between final progress ratings on shyness and two of the other 
targets, trauma and phobias/fears (Pearson’s r = 0.37 and 0.42, p < 0.01) compared to 
correlations between other targets (rs ranging from 0.50 to 0.55, p < 0.001).  The other four 
targets were retained due to (a) their various similarities noted in the introduction and (b) 
adequate Cronbach’s alphas for anxiety-related progress ratings when examining episodes in 
which all four targets occurred together (n = 155, α = 0.76) or when any combination of three of 
the four targets occurred (n = 1516, range of α = 0.73 - 0.75).  These targets occurred at varying 
rates in the sample, with anxiety occurring in 3636 (54.9%) episodes, phobias/fears occurring in 
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3469 (52.4%) episodes, avoidance occurring in 2231 (33.7%) of episodes, and traumatic stress 
occurring in 1480 (22.4%) of episodes. 
The study’s date range of July 1, 2006, through August 31, 2015, noted above was 
chosen because July 2006 was the first month in which providers were required to complete an 
MTPS form in order to receive reimbursement for services, thereby substantially reducing the 
frequency of missing MTPS data (CAMHD, 2012). 
 Analysis 1: Predicting the use of exposure when anxiety-related targets were 
present.  Therapist endorsement of the practice element (PE) of exposure on the MTPS was 
used to derive a dichotomous criterion variable.  If a therapist endorsed using exposure as an 
intervention during an episode in which any of the four anxiety-related targets described were 
endorsed on any MTPS, this variable was coded as 1, otherwise this variable was coded as 0.   
It was hypothesized that the probability of exposure therapy use would increase as a 
function of the recency of a given treatment episode.  Treatment end date, broken into 15 six-
month increments and one two-month increment, was therefore included in the analysis as a 
predictor variable.  This served as a proxy for time of service and more accurately captured the 
entirety of a service episode than treatment start date.  Six-month time increments were used to 
better interpret results (i.e., an estimate of the increase in odds of exposure endorsement per one 
day increase in episode end date was too small for statistical software to report, whereas 
utilizing a variable indicative of year increments might not provide a sufficiently-detailed 
analysis of change over time).  The two-month increment reflected the final two months of the 
date range of the study (July 1, 2015 through August 31, 2015), and included those episodes 
that either (a) were closed in the last two months of data collection or (b) were ongoing at the 
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end of data collection.  The n-size of episodes within this shorter date interval was similar to 
that of the other six-month ranges (n = 379; mean number of episodes per date range = 348, SD 
= 67).  
It was also hypothesized that in any given treatment episode in which an anxiety-related 
target was endorsed, the degree to which externalizing treatment targets were also endorsed 
would predict reduced likelihood that exposure was used in that treatment episode.  
Externalizing targets, as defined by Milette-Winfree & Mueller (2017), included: willful 
misconduct/delinquency, oppositional or non-compliant behavior, hyperactivity, attention 
problems, aggression, self-injurious behavior, anger, empathy, and peer or sibling conflict.  A 
continuous variable that reflected the proportion of months in a treatment episode in which any 
of these externalizing problems was endorsed served as a predictor variable.  
It was hypothesized that therapists with Ph.D. degrees were more likely to use exposure.  
There were only 12 Ph.D. clinical psychologists represented in the dataset, which was an 
insufficient n size to gauge potential effects of Ph.D. degree on likelihood of using exposure.  
Therefore Ph.D. clinical psychologists were subsumed within all doctorate-level clinical 
psychologists, resulting in a total n of 63 doctorate-level providers.  See Table 3 for descriptions 
and frequencies of the highest degrees held by treatment providers. 
Given the few hypotheses regarding factors predicting likelihood of exposure use, a 
number of other factors were also included as confounding variables and to explore whether 
previously unreported treatment characteristics might affect therapists’ usage of exposure 
therapy.  These included level-of-care as described in Appendix A (e.g., intensive in-home 
therapy, multisystemic therapy, therapeutic foster care, hospital-based care, etc.), youth age, 
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youth sex, youth race, presence of an anxiety disorder diagnosis, number of previous treatment 
episodes, whether a youth received exposure in a previous episode, youth’s emotional 
impairment as measured by the CAFAS mood/emotions subscale score at treatment episode 
onset, mean number of practices other than exposure endorsed per month, type and total number 
of unique anxiety-related problems targeted in the episode, and proportion of episode months in 
which at least one anxiety-related problem was targeted.  The relationship between exposure use 
and the presence in a treatment episode of each of the four anxiety-related targets (anxiety, 
avoidance, phobias/fears, and traumatic stress) was examined at the bivariate level, and those 
targets that significantly predicted exposure use were entered in the full model.   
Analysis 2: Predicting anxiety-related improvement as a function of the use of 
exposure. “Total anxiety progress,” a composite score representing mean therapist final 
progress rating on any anxiety-related targets endorsed within a treatment episode as reported 
on the MTPS (with scores ranging from 0 to 6) served as the criterion variable for this analysis.  
This composite score was created due to both conceptual and empirical relationships between 
the four anxiety targets under study (anxiety, avoidance, phobias/fears, and traumatic stress). 
Conceptual relationships are discussed in the introduction, and were supported by preliminary 
analyses indicating that progress ratings of any two anxiety targets occurring together were 
significantly correlated and progress ratings across three or more anxiety targets occurring 
together were acceptably consistent (see Data Analytic Strategy for statistical information).  The 
resulting composite score had a mean of 2.89, a standard deviation of 1.49, and a reasonably 
normal distribution (see Figure 1 for a visual depiction). 
The primary predictor variable of interest in Analysis 2 represented the amount of 
exposure use during a treatment episode.  Multiple ways of measuring this variable were 
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considered (i.e., as a dichotomous variable indicative of any use/no use in an episode, as a 
continuous variable indicating the number of months in which exposure was endorsed, as a 
categorical variable reflecting ranges of months of exposure use, and as a proportion of months 
in which exposure was endorsed out of total episode months).  A four-category variable was 
chosen because (a) this method allowed for the optimal balance of distribution of episodes 
across categories and maximum number of such categories (see Results), and (b) this variable 
allowed for the examination of the hypothesis that more months of exposure use would be 
associated with improved treatment progress, as suggested by Crawford and colleagues (2017) 
and Feske & Chambless (1995).   Categories were defined as no months of exposure use, one 
month of use, two to three months of use, and four or more months of use.  This variable was 
analyzed along with other covariates related to agency (level-of-care), therapist (doctorate level 
of education), client (sex, race, age), and episode (anxiety diagnosis, recency of treatment 
episode end date, treatment episode length, proportions of episode months in which anxiety-
related problems and externalizing problems were targeted, number of previous treatment 
episodes for the youth,  mean number of therapeutic practices used per month, and emotional 
functional impairment at onset of episode as measured by CAFAS Emotions/Feelings subscale 
score).  While many of these covariates were conceptualized as confounds, the interaction 
between exposure use and other categorical variables (e.g., therapist doctoral degree, agency 
level-of-care) was examined if main effects were found for those covariates.  Related to the 
hypothesis that early exposure use within an episode would also enhance outcomes, a 
continuous variable indicative of which month exposure was first identified on the MTPS 
within a given episode was examined outside of the main analyses to determine if it was 
associated with improved treatment progress. 
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Data preparation.  First, minimum and maximum values (i.e., response ranges) for 
each item, subscale, and totals of all measures were calculated to identify impossible values and 
potential data entry errors.  MTPS data were inspected to ensure that each MTPS included had 
at least one anxiety-related treatment target, respective progress ratings for each selected 
treatment target, and at least one PE.  Of the 40,372 MTPS entries with an anxiety-related target 
endorsed, 674 (1.7%) either did not report an associated progress rating or did not identify any 
PE, which was consistent with previous research (e.g., Love, et al., 2010).  Second, the means, 
standard deviations, skewness, and kurtosis of relevant variables were examined in order to 
obtain a preliminary and broad understanding of the data.  Finally, the assumptions of 
conducting  multi- level models (MLMs) of cross-classified data were analyzed (e.g., normal 
distribution of residuals for continuous criterion variables, sufficient variance in the criterion 
variable accounted for by the various classifications of data in the analysis, and non-
multicollinear predictors; Heck et al., 2013; Quene & van den Bergh, 2004; Raudenbush & 
Byrk, 2002).  Results of these analyses are reported in Appendix F.  
Missing data.  As described below, multilevel modeling of cross-classified data was 
utilized as the major analytic strategy for this study.  It is common for participants within a 
cross-classified study to have unequal (and missing) amounts of data (Heck et al., 2013; Quene 
& van den Bergh, 2004).  With multilevel data structures and maximum likelihood estimation, 
listwise deletion is not necessary.  Where full information maximum likelihood estimation is 
available, unbalanced higher level sample sizes and missing data can be accommodated, or 
multiple imputation can be utilized to replace missing values; however, the assumption that the 
missing data in the sample are missing at random (MAR) should be examined (Quene & van 
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den Bergh, 2004; Little & Rubin, 1987). Retaining individuals with partial data is actually 
useful in developing an argument that the data are likely missing at random.  
As in previous studies utilizing CAMHD data, CAFAS data were missing from the 
dataset at a high rate (930 out of 6616 treatment episodes; Milette-Winfree & Mueller, 2017).  
The only other data that were missing involved four episodes in which a therapist’s degree 
status was not reported.  A Missing Values Analysis run in the Statistical Package for Social 
Sciences (SPSS) determined the data were Missing At Random (Little & Rubin, 1987).  As 
such, an episode-level multiple imputation with five iterations was used to generate five 
simulated datasets in which the 930 missing CAFAS values and four degree values were 
estimated and imputed.  Single- level analyses of these five simulated datasets were then 
compared to determine whether any coefficients, F values, or p values changed significantly 
across the original dataset and the five iterative datasets.  In the case of both Analysis 1 and 
Analysis 2, none of these values changed substantially to suggest they might affect main 
analyses. Therefore, each analysis was run twice, both including and excluding the CAFAS 
mood subscale score variable and the degree variable, and results were compared.  When 
CAFAS score and degree were added into the models, no relationships between other predictor 
variables and the criterion variables changed significantly for either analysis.  Therefore the 
analyses reported below include the CAFAS Mood/Emotions score and degree variables.  This 
prompted the exclusion of the 934 episodes in which CAFAS score and doctoral degree status 
were missing for main analyses, resulting in a total of 5,682 episodes analyzed in the two main 
statistical models.  
A second issue related to missing data involves the consideration of empty cells when 
examining categorical interactions in a statistical model.  In this dataset, the interaction between 
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categories of exposure use and categories of level-of-care was examined.  This interaction 
resulted in 36 cells of data, eight of which were empty (e.g., exposure use was never reported 
for four or more months in the sexual misconduct residential treatment level-of-care; see Table 
9 for additional empty cells).  Cochran (1952) indicates that such observed zero values in cells 
are not problematic as long as the expected values for these cells are not below five in more 
than 20% of cells under analysis.  Only two of the 36 cells examined (5.5%) had expected 
values less than 5, suggesting that these empty cells did not affect the validity of these analyses. 
Main analyses.  Cross-classified multi- level analyses were chosen due to the imperfect 
nesting of episodes within higher-order levels.  Cross-classified data structures differ from 
typical hierarchical data structures in that for the latter data structure each individual (or level-1 
subject) is nested in only one higher level unit.  In contrast, in cross-classified data structures, 
some individuals may be fully nested in higher level units, while others may be only partially 
nested (i.e., cross-classified) in more than one higher level unit (Raudenbush & Byrk, 2002).  
For example, three treatment episodes might be nested within one youth, but each episode-
youth combination could be nested within a different therapist and a different provider agency.  
This data structure can be more accurately measured using cross-classification modeling as 
opposed to hierarchical MLM (Fielding & Golding, 2006).  The study followed the guidelines 
discussed by Heck et al. (2013), Peugh (2010), and Fielding & Goldstein (2006), and are 
described in detail in Appendix F.  
Supplemental Analyses.  Several additional analyses were performed to (a) test a 
hypothesis that could not be evaluated using the main analyses and (b) further assess level-of-
care characteristics.  Regarding (a), episodes in which exposure was utilized were isolated and 
the relationship between the month in which exposure was first utilized and total anxiety 
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progress was examined.  A uni-level generalized linear modeling approach was utilized, and 
this relationship was examined in the context of the covariates used in Analysis 2 above.  
Regarding (b), level-of-care differences in two variables (proportion of months of anxiety 
targets and emotional impairment at treatment onset) were examined to better understand the 
differences in anxiety progress across levels-of-care.    
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 Chapter 3: RESULTS 
 Exposure was utilized during one or more months in 20.7% (n = 1372) of all episodes 
under study.  In 156 (11.4%) of these episodes, exposure use occurred only in months without 
any anxiety-related target; these were nonetheless categorized as exposure episodes in Analysis 
1.  Given that the main predictor variable of interest in Analysis 2 measured the number of 
months in which exposure co-occurred with at least one anxiety target, these 156 episodes 
received a score of 0 on that variable and were thus added to the 5,244 episodes in which 
exposure was not used for that analysis.  Mean total anxiety progress ratings were similar 
between these two groups of episodes (m = 2.79 and 2.86, respectively).  The number of months 
that exposure was used coincident with the endorsement of anxiety-related problems varied.  It 
was most commonly used for one month (n  = 510, 37.2% of exposure episodes), followed by 
2-3 months (n = 373, 27.2% of exposure episodes) and then 4 or more months (n = 333, 24.3% 
of exposure episodes).  
Analysis 1: Predicting the use of exposure when anxiety-related targets were present. 
A cross-classified logistic regression model examined predictors of exposure use in the 
context of random variance between therapists and service provider agencies.  The results of the 
cross-classified model are presented in Table 5.  As noted in Method: Missing Data, episodes 
missing CAFAS scores and information related to doctoral degree were removed from analyses, 
resulting in 5682 episodes analyzed.  Note that the intercept has a highly significant negative 
beta value because (a) exposure was only used in 20.7% of episodes, and as such the odds of 
exposure being used without considering any variables in the model are below 1, resulting in a 
beta value that is necessarily negative and (b) reference categories reflected by the intercept 
were most commonly conditions in which exposure was less likely to occur (i.e., no anxiety 
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diagnosis, shorter episode length, fewer practices used in treatment and fewer anxiety targets 
selected), further lowering the beta value and odds ratio.  Episode end date recency (measured 
in six month intervals) increased the odds of exposure use, odds ratio (OR) = 1.03, B = 0.03, t = 
2.37, p =0.02.  Given the approximately nine years and 16 date intervals encompassed within 
the time period of the study, this suggests that the most recent episodes were 60% (odds ratio = 
1.0316 or 1.60) more likely to include exposure than the earliest episodes.  As the proportion of 
months in which externalizing targets were endorsed increased from 0 to 1, the odds of 
exposure use decreased by 60%, odds ratio = 0.40, B = -0.91, t = -5.88, p <0.001.  There was no 
association between doctorate degree and exposure use, B = -0.11, t = -0.35, p = 0.73.  
The above results persisted despite several other significant predictors of exposure use.  
The two most robust of these predictors were total months in the treatment episode, B = 0.09, t 
= 11.13, p <0.001, odds ratio [OR] = 1.09, and mean total number of practices/interventions 
utilized per month, B = 0.10, t = 12.17, p <0.001, OR = 1.10.  For every additional month that a 
treatment episode persisted, the odds of exposure being used increased by 9%.  Similarly, with 
every additional intervention strategy (other than exposure) used in a treatment month, odds of 
exposure use increased by 10%.  Given a mean (SD) of 16.71(9.91) practices other than 
exposure endorsed per treatment month, this indicates that as the number of practices used 
increased by one standard deviation, the odds of exposure use increased by a magnitude of 2.57 
(157%). 
Several other factors also predicted the likelihood of exposure use.  These included the 
youth’s CAFAS Mood/Emotions score at start of treatment (B = 0.02, t = 2.41, p =0.02, OR = 
1.016), number of unique anxiety targets (ranging from 1 to 4) identified once or more during 
an episode (B = 0.26, t = 3.78, p <0.001, OR = 1.30), proportion of total episode months in 
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which anxiety targets were selected (ranging from 0.03 to 1.00, B = 0.55, t = 2.78, p <0.001, OR 
= 1.74), and presence of an anxiety diagnosis (B = 0.28, t = 3.78, p <0.001, OR = 1.32).   Given 
that CAFAS scores are in 10-point increments, this suggests that one unit increase in CAFAS 
score (e.g., from 10 to 20) resulted in a 1.17-fold (17%) increase in odds of exposure use.  The 
odds of exposure use increased by 30% for each additional anxiety target endorsed in an 
episode, by 74% as the proportion of episode months in which anxiety was targeted increased 
from 0 to 1, and by 32% when a youth was diagnosed with an anxiety-related disorder. 
When examined at the bivariate level, the presence of the phobias/fears target in an 
episode resulted in a reduced likelihood of exposure use.  This relationship persisted in the full 
model, with the endorsement of phobias/fears any time in an episode resulting in a 27% 
decrease in the odds of exposure use, B = -0.31, t = -2.67, p =0.01, OR = 0.73.  Regarding level-
of-care, the hospital-based service classification was chosen as the reference category because it 
had the highest rate of exposure use among all levels-of-care (37.9% of cases).  Placement in 
either sexual misconduct residential treatment or crisis/respite home resulted in a respective 
96% and 95% decreased likelihood of exposure use, Bs = -3.15 & -2.94, ts = -2.62 & -2.57, ORs 
= 0.04 and 0.05, p =0.01, compared to hospital-based placement.  Notably, placement in the 
functional family therapy level-of-care was not a significant predictor of exposure use despite 
no endorsement of exposure in any episode within this level-of-care.  This finding is due to an 
extremely high standard error for the beta value of this variable stemming from an absence of 
variance and should be interpreted with caution.  Finally, Asian youth who did not identify as 
mixed-race were more likely to receive exposure than all other youth, B = 0.45, t = 2.50, p 
=0.01, OR = 1.56. 
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Covariance parameter estimates indicated that agencies and clinicians continued to 
account for significant random variance after fixed effects were added into the equation, (ICC = 
0.195 for agency, ICC = 0.380 for therapist, random variance estimates = 0.80 and 2.02 
respectively, Z-scores = 2.68 & 8.54, p<=0.01).  Notably, this model resulted in a sizeable 
decrease in random variance accounted for by agency (compared to an ICC of 0.301 in the null 
model), and a slight increase in the random variance accounted for by therapist (compared to an 
ICC of 0.355 in the null model).   
Finally, the cross-classified model correctly predicted exposure use/non-use in 89.0% of 
cases, a significant increase compared to the null model’s 79.3% successful prediction rate 
(Wald z = 21.58, p<.001). The model correctly predicted 61.6% of the cases in which exposure 
was used and 96.2% of the cases in which exposure was not used.  
Analysis 2: Predicting anxiety-related improvement as a function of the use of exposure. 
 Main effects model.  A cross-classification linear regression model initially examined 
main effects of exposure use and other covariates related to total anxiety progress (see Table 6 
for results).  As in Analysis 1, episodes missing CAFAS scores and information related to 
doctoral degree were removed from analyses, resulting in 5,682 episodes analyzed.  As 
hypothesized, 4+ months of exposure in the presence of anxiety targets was associated with 
higher total anxiety progress.  Specifically, the beta values for the no months, one month, and 
two to three month categories of exposure were significantly negative compared to the 4+ 
months category, range of B = -0.37 to -0.25, range of t = -3.89 to -2.23, p ≤0.03 (see Table 7 
for estimated marginal means across exposure use categories).  There were no significant 
differences between the three lower-use categories, with mean estimated progress ratings falling 
between 3.05 and 3.18.  Comparing the standardized difference between estimated mean anxiety 
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total progress for episodes with high (4+ months) exposure use to mean anxiety total progress 
ratings for all other episodes resulted in a Cohen’s d effect size of 0.38.  This result persisted in 
the context of a number of other factors that also predicted total anxiety progress, described 
below. 
Total months of treatment (B = 0.04, t = 14.23, p <0.001) and mean practices used per 
month in an episode (B = 0.03, t = 8.68, p <0.001) predicted total anxiety progress.  The 
proportion of total episode months in which externalizing targets were endorsed was associated 
with reduced total anxiety progress (B = -0.19, t = -3.20, p =0.001), while the proportion of 
months in which anxiety targets were a focus of treatment predicted a higher total anxiety 
progress score (B = 0.43, t = 6.03, p <0.001).  CAFAS Mood/Emotions score at treatment onset 
(B = -0.01, t = -3.67, p <0.001) and number of previous treatment episodes (B = -0.03, t = -4.83, 
p <0.001), both predicted lower total anxiety progress.  Treatment progress also differed as a 
function of level-of-care, with the lowest mean anxiety progress in the community-based 
residential treatment setting (estimated marginal mean [EMM]= 2.47, S.E. = 0.16; this level-of-
care served as the reference group in the analysis) and the highest mean anxiety progress in the 
multisystemic therapy (EMM = 3.78, S.E. = 0.18) and functional family therapy (EMM = 3.85, 
S.E. = 0.27) treatment settings.  See Table 7 for total anxiety progress score EMMs for all levels 
of care.  The difference in mean anxiety progress between community-based residential 
treatment and all other levels-of-care either met or approached statistical significance (range of 
ts = 1.88-6.21, range of ps = 0.001 – 0.07).  All the above results persisted after holding other 
non-significant factors constant, including episode end date, therapist doctorate degree, the 
presence of an anxiety diagnosis, and youth sex, age, and race. 
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Interaction model.  Given the significant differences in total anxiety progress across 
various levels-of-care, an interaction effect was tested to determine whether the main effect of 
exposure use occurred across or primarily in specific levels-of-care.  As can be seen in Tables 8 
and 9, the overall interaction effect was significant, F(16) = 3.30, p <0.001, with the highest 
category of  exposure use (4+ months) predicting improved total anxiety progress when 
compared to the three lower-use categories specifically in the community-based residential 
treatment setting.  Given that 4+ months of usage was the reference category, this difference is 
reflected by significantly negative beta values of the other three usage groups as reported in 
Table 8, range of Bs = -0.97 to -1.27, range of ts -7.14 to -4.49, p<0.001.  Effect size (i.e., the 
standardized mean difference in total anxiety progress score between anxiety episodes with 4+ 
months of exposure and all other episodes within the community-based residential treatment 
level-of-care) as measured using Cohen’s d was 0.50.  This interaction occurred in the context 
of the factors reported in the main effects model above. 
In both models utilized in Analysis 2, the cross-classifications of youth, clinician, and 
agency continued to account for significant random variance after fixed effects were entered 
(respective variance parameter estimates = 0.14, 0.33, and 0.07, Wald Zs = 4.32, 9.16, and 2.06, 
ps <0.001, <0.001, =0.04, respectively).  The estimated random variance accounted for by youth 
classification decreased from 9.2% to 6.7% and the estimated random variance accounted for by 
agency decreased from 14.5% to 3.15%.  The estimated random variance accounted for by the 
therapist level increased from 14.5% to 16.1%.  This was due to a decrease in the residual 
episode-level random variance in the model and not caused by an increase in the covariance 
parameter related to therapist.  These results suggest that the fixed effects in the model account 
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for approximately 27% of the variance between youth, 78% of the variance between agencies, 
and little or no variance between therapists. 
Results of supplemental analyses.  Contrary to expectation, earlier initiation of 
exposure use in a treatment episode was associated with reduced total anxiety progress (B = 
0.026, t = 3.11, p = 0.002).  Given the potential confounds of short treatment episodes and low 
dosages of exposure contributing to this reduction in anxiety progress scores, the sample was 
further limited to only those cases in which exposure was endorsed for 4 or more months and 
the analysis was re-run.  Earlier exposure use was not associated with anxiety progress for this 
subset of episodes (B = 0.006, t = 0.36, p = 0.72). 
Analyses of variance indicated that both the proportion of months in which anxiety 
targets were endorsed and a youth’s emotional impairment at treatment onset differed as a 
function of level-of-care, F(8,6607) = 238.02,  p<0.001,  F(8,5677) = 39.66, p<0.001, 
respectively.  Regarding months of anxiety targets, this proportion score was significantly lower 
in functional family therapy (mean = 0.48) and multisystemic therapy (mean = 0.50) than in 
other levels-of-care (overall mean = 0.67).  Regarding emotional impairment at treatment onset, 
youth had significantly higher initial mood/emotions CAFAS scores in the hospital-based level-
of-care (mean = 23.11) than in other levels-of-care (overall mean = 17.89). 
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Chapter 4: DISCUSSION 
 This study is the first to specifically examine exposure therapy for anxious youth across 
multiple levels of care in a child and adolescent mental health system to determine (a) factors 
associated with its use and (b) its association with outcomes.   Exposure was used in less than 
one quarter of anxiety-related treatment episodes.  As hypothesized, exposure was more likely 
to be used in more recent episodes and less likely to be used when externalizing problems were 
more often targeted.  Contrary to the hypothesis, doctoral level of training was unrelated to 
exposure use.  These results persisted despite many other predictors of exposure use in the 
cross-categorical model.  Four predictors that seemed indicative of the salience of anxiety 
(presence of an anxiety-related diagnosis, higher CAFAS Mood/Emotions impairment score at 
treatment onset, number of different anxiety targets endorsed, proportion of episode months in 
which anxiety problems were a focus) predicted higher exposure use, while a predictor 
potentially indicative of less salient (or less acute) anxiety predicted reduced use (selection of 
the phobias/fears target, discussed below).  Two additional treatment variables (mean number of 
practices endorsed per month and number of episode months), one agency-level predictor 
(level-of-care) and two variables that were difficult to interpret (whether the youth in treatment 
received exposure in a previous episode and/or was of Asian race) predicted greater likelihood 
of exposure use. Youth age, sex, and number of previous episodes were unrelated to exposure 
use. 
Regarding exposure’s relationship to improved outcomes, four or more months of 
exposure use was associated with a higher score on the composite measure of anxiety-related 
treatment progress.  When the interaction between exposure use and level-of-care was 
examined, this association was found to occur primarily in community-based residential 
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treatment.  These findings persisted after including multiple statistically-significant covariates 
in the cross-categorical model.  Effect sizes for the difference in anxiety progress between high 
monthly exposure use and all other cases were moderate (Cohen’s d = 0.38 for the main effect 
model and 0.50 for the interaction model).  Total months of treatment, proportion of episode 
months in which anxiety problems were targeted, and mean number of practices (other than 
exposure) used per month predicted higher progress.  Higher number of previous episodes, 
proportion of months in which externalizing problems were targeted, and level of emotional 
impairment as indicated by CAFAS mood/emotions score predicted less progress.  Other 
variables (therapist doctorate degree, youth sex, youth age, presence of an anxiety diagnosis, 
and episode end date) did not significantly predict progress. 
Exposure utilization. As hypothesized, exposure was used more frequently over time, 
likely due in part to the dissemination and implementation efforts conducted nationally and/or 
undergone in this system of care over the past decade (Nakamura et al., 2014).  However, the 
overall 20.7% nine-year rate of exposure use was low (and within the range of what has been 
found in other studies; e.g., Foy et al., 1996).  On the positive side, the percentage of youth who 
received exposure for anxiety problems rose from 12.2% in episodes that began in the last six 
months of 2006 to 20.5% in episodes that began in the first half of 2015.  These findings 
converge with previous evidence that therapists’ acceptance and use of evidence-based practices 
can be fostered through therapist training efforts (e.g., Becker et al., 2012).  However, there are 
three additional caveats to this increase in the usage rate of exposure.  First, and as discussed 
below, exposure use does not necessarily equate to effective exposure use.  Second, when used, 
exposure was most commonly reported for only one month of treatment (in the context of a 
mean number of nine episode months).  Third, reliance on therapist self-report opens up the 
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possibility that endorsement of exposure use reflects some other reporting bias.  For example, 
therapist endorsement of evidence-based practices like exposure might reflect organizational 
pressures stemming from dissemination efforts rather than genuine execution of a given 
practice.  While this possibility cannot be disconfirmed, coding of session recordings by 
Borntager and colleagues (2013) suggests that when therapists endorsed using exposure 
practices, session coders found that exposure was indeed conducted, but commonly 
characterized as a “brief/fleeting mention or incomplete execution” (Borntrager et al., 2013, p. 
378).  This suggests that many therapists might have gleaned a sufficient knowledge of 
exposure practices from training efforts or other sources to introduce them in session, but an 
insufficient knowledge to thoroughly implement them.  In sum, while the reported use of 
exposure for anxiety is low and of uncertain quality in usual care, there is a discernible and 
encouraging reported increase in its use over the last nine years, at least in this system of care.  
Also as predicted, and complimentary to recent research indicating that therapists 
disproportionately focus on externalizing treatment targets in this system of care (Milette-
Winfree & Mueller, 2017), the proportion of months in which a therapist endorsed externalizing 
treatment targets was associated with a reduced likelihood of exposure use.  This finding 
provides preliminary evidence suggesting that a disproportionate focus on externalizing 
problems results not only in less focus on internalizing targets but also less use of exposure even 
in cases with anxiety-related targets.  The reasons for this pattern are unknown.  Externalizing 
problems are common in this system-of-care, and they continued to be common in this sample 
despite its restriction to youth experiencing anxiety-related problems.  Indeed, disruptive 
behavior disorders (typically Oppositional Defiant Disorder and/or Conduct Disorder) were the 
most common primary diagnoses in this study and occurred at more than double the rate of 
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anxiety-related primary diagnoses.  This presence of externalizing problems might prompt 
therapists to prioritize them by default (or by biased heuristics) in many of these cases, leading 
to less use of exposure.  Even when anxiety is present and targeted, exposure can be a difficult 
practice to implement given it is thought to be resource-consuming and anxiety-provoking (e.g., 
Chu et al., 2015; Becker et al., 2004).  Indeed, the overall low rates of exposure use found in 
other studies could be due at least in part to clients presenting with multiple problems, requiring 
therapists to make such difficult choices. 
Findings also suggest that therapists are more likely to use exposure when anxiety is a 
more salient problem (as evidenced by high emotional impairment at treatment onset, the 
presence of an anxiety diagnosis, a high proportion of months in which anxiety was treated, and 
the number of different anxiety targets identified in treatment), which suggests an 
acknowledgement and understanding of the potential benefits of exposure use, especially when 
anxiety is a major or salient problem.  This is additionally, if tentatively, supported by the 
finding that targeting of phobias/fears in treatment was associated with reduced likelihood of 
exposure use.  In this system of care, where youth must meet criteria for “severe 
emotional/behavioral disturbance” to gain entry (CAMHD, 2012), the common phobias and 
fears that a youth experiences might be a less-critical focus of treatment than other anxiety-
related functional impairment (e.g., school refusal, major trauma, or panic attacks) and might 
therefore be dealt with using other, less demanding, strategies.   
Contrary to the stated hypothesis, none of the random variance between therapists was 
captured by whether a therapist had a doctorate degree.  In this diverse system of care, where 
therapists receive training from a variety of institutions with diverse training philosophies, a 
doctorate degree simply might not signify a particular allegiance to evidence-based practice 
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utilization (Nakamura et al., 2014).  Additionally, research correlating Ph.D. degree with 
increased exposure use has typically been done using surveys of clinicians at large (e.g., 
indexed by state licensing boards as in Whiteside et al., 2016).  Given this research occurred in 
a state system of care, related organizational characteristics (e.g., provider agency norms or 
supervisors’ preferences for intervention strategies) might influence therapists’ decisions above 
and beyond the effect of education level.  That said, there remained a significant amount of 
variance in the likelihood of exposure use between therapists.  Identifying what therapist factors 
predict exposure use could improve targeting of dissemination and implementations efforts.  
Episode level-of-care accounted for considerable variance in exposure use, with children 
receiving hospital-based care, community-based residential treatment, and intensive in-home 
therapy the most likely to receive exposure, while disruptive youth in high-security sexual 
misconduct residential treatment and children receiving functional family therapy received 
exposure rarely if at all, even though all episodes in the study included some anxiety-related 
targets.  The relatively high rate of exposure use in hospital-based care is somewhat unexpected, 
given youth who received hospital-based services were highly- impaired and frequently 
experiencing significant crises (e.g., suicidality, psychosis, or mania) upon onset of services, 
and episode length was typically quite short (mean months of treatment = 1.50, SD = 1.79).  
That exposure was never endorsed in the functional family therapy level-of-care is not 
particularly surprising given that this therapeutic modality typically targets disruptive youth and 
attempts to address their functional impairment by focusing on family relational functioning 
(Alexander & Robbins, 2011).  Similarly, the sexual misconduct residential treatment centers 
under study serve highly aggressive male youth who often have engaged in sexually deviant or 
assaultive behaviors, and therefore anxiety problems might not typically be prioritized in 
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treatment (CAMHD, 2012).  Indeed, this could reflect and extend the more general finding of 
externalizing targets being associated with less exposure.  When sexual offense and/or other 
serious externalizing problems (e.g., violence toward others and recidivism) occur, anxiety is 
still sometimes targeted but it is not targeted with exposure.  Given the specialized nature of 
these programs, treatment components are likely highly-prescribed, with a predominant focus 
on the serious rules/norms violations that are the cause for program entry.  As such, staff 
training in exposure at such programs might not be feasible, cost-effective, or perceived as 
relevant by providers or program administrators.  
As noted, the significant relationship between exposure use and treatment progress 
persisted despite total episode length and number of practices per month predicting the 
likelihood of exposure use.  These variables seem to best be interpreted as confounds, given that 
based on basic probability, the likelihood of a therapist randomly endorsing exposure use on the 
MTPS increases for every additional month in treatment and for every discrete practice the 
therapist has selected (e.g., if the therapist has selected 32 of 63 practices in a month, the 
random chance of one of those practices being exposure is about 51%). 
Regarding the remaining two predictors of increased exposure utilization, little more 
than conjecture can be offered.  Youth who received exposure therapy in a past episode were 
more likely to receive it than youth who had never received it, and this effect persisted after 
removing the first episode for a given youth from analyses.  This finding might reflect 
continuity in treatment planning across episodes, or it could be indicative of a youth/family 
requesting a specific intervention across different providers.  While these hypotheses cannot be 
addressed with the data available for this study, the latter would comport with the dissemination 
and implementation efforts that have occurred in this system of care, which have focused not 
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only on therapist training, but also on initiatives to educate mental health consumers on the 
benefits of using evidence-based practices and to empower them to seek out such services 
(Nakamura et al., 2014).  Finally, regarding Asian race predicting increased likelihood of 
exposure use, this is a difficult finding to interpret in the present study given that the multi-
racial category in this population is highly comprised of individuals of at least partial Asian 
descent.  Perhaps those youth identifying as fully Asian might undergo acculturation issues that 
materialize as avoidance or anxiety related to engaging in an unfamiliar socio-cultural system 
that incorporates a mix of eastern, western, and Pacific island cultural norms, and therapists 
react to this avoidance by fostering efforts to ‘expose’ such youth to these cultural norms.  
Follow-up studies might benefit from examining anxiety problems among ‘pure’ Asian youth to 
determine whether they are differentiated from those of other Hawaii youth. 
Exposure and outcomes.  This study is the first to indicate that extended utilization of 
exposure (4+ months) in a treatment-as-usual context, when compared to reasonably analogous 
treatment that included no or few months of exposure, coincided with substantially improved 
outcomes on a composite measure of anxiety treatment progress.  This association occurred 
despite a variety of other significant factors predicting treatment progress.  However, it is 
crucial to note that this relationship was driven by the interaction between (a) four or more 
months of exposure use in an episode and (b) treatment delivery in a community-based 
residential treatment setting.  While there was a significant relationship between 4+ months of 
exposure and anxiety progress when the interaction effect was not included in the analysis 
(overall Cohen’s d = 0.38), the intensive in-home level-of-care was the only other placement in 
which anxiety progress was highest for 4+ months of exposure use, and this relationship was 
small and non-significant (See Table 9 for estimated marginal means).  These results indicate 
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that while the significant association between high usage of exposure and treatment progress 
occurred across the sample, this association was primarily due to treatment episodes occurring 
in the community-based residential setting. 
Results imply that when exposure was used over sufficient time in an appropriately-
controlled treatment setting, positive outcomes were observed.  Why these two seemingly 
necessary conditions might apply is not known.  One possibility is that they allowed for the 
reduction of variability in the quality and context of exposure delivery in the system of care at 
large in order for exposure-specific effects to emerge.  Regarding the quality of exposure, as 
Garland et al. (2010) and Borntrager et al. (2013) have noted, community therapists often 
deliver evidence-based practices with low fidelity.  While no direct measure of fidelity or 
dosage exists in the current dataset, measuring the number of months in which exposure was 
used allows for the potential filtering of episodes in which, for example, exposure was 
attempted for one session and then stopped, or possibly when a “brief/fleeting mention or 
incomplete execution” of exposure occurred (Borntrager et al., 2013, p. 378).   
 Regarding the context of exposure use, the finding that high amounts of exposure were 
related to improved progress primarily in the community residential treatment setting seems to 
suggest that the residential treatment context balances sufficient structure and duration of 
exposure with an adequately stabilized population of youth to allow for exposure to have a 
potential effect on anxiety-related outcomes.  A majority of youth receiving services in this 
system of care experience significant environmental, social, and economic stressors (Chorpita & 
Daleiden, 2009).  Given therapists’ reported practical and logistical difficulties with delivering 
exposure, such youth might not have the sufficient support structure to ensure that exposure is 
delivered effectively in home, explaining why exposure, even in high amounts, did not result in 
63 
 
statistically improved outcomes in the intensive in-home level-of-care.  Studies have suggested 
that youth are placed in residential treatment in part to circumvent the treatment barriers 
inherent in a difficult home environment (Pottick, Warner, & Yoder, 2005).  Such might also be 
the case here: when youth are placed in a setting in which conditions for exposure treatment are 
supportive (e.g., treatment sessions cannot easily be avoided; between-session exposure 
homework is undertaken and monitored), the potential of exposure therapy is more fully-
realized.  These conditional findings offer an interesting analog to efficacy studies, in which 
various common advantageous conditions (e.g., motivated, treatment-seeking families, 
relatively low levels of comorbid externalizing problems, and service delivery in carefully-
controlled and well-supervised settings) are also likely to contribute to enhanced treatment 
outcomes. 
On the opposite end of the level-of-care spectrum, it is also noteworthy that while 
exposure was relatively frequently-used in the hospital-based treatment setting, it did not result 
in improved outcomes.  Hospital-based services are typically indicated for youth undergoing 
significant mental health crises (e.g., suicidal ideation/attempt; acute psychosis, etc.; CAMHD, 
2012), and these youth had significantly higher CAFAS mood/emotions scores than those in any 
other level-of-care.  That such youth do not benefit from exposure therapy, even with prolonged 
months of use, suggests that very high youth functional impairment might inhibit the 
implementation and/or benefits of exposure therapy.   All this said, these findings do not imply 
that the qualities inherent in 4+ months of community-based residential exposure treatment 
cannot be replicated in shorter treatment episodes or other levels-of-care.  While there is little 
evidence of any larger scale iatrogenic effects of exposure (worsening of anxiety-related 
targets), these findings could serve as an important caveat for a therapist considering exposure 
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use and its cost-effectiveness: if exposure is to be used, it should be used thoughtfully, with a 
commitment to sufficient dosage, and having planned and problem solved for potential barriers. 
Suggestive of a ‘more is better’ approach to treating anxiety, the length of treatment 
episode, number of practices endorsed per month, and proportion of the episode in which 
anxiety problems were a focus of treatment were also predictive of improved anxiety treatment 
progress.  A similar positive relationship between number of practices used and progress (a) on 
disruptive behavior problems, (b) on mood difficulties, and (c) within the community-based 
residential service setting in this system-of-care has been previously found, suggesting that  
more and more diverse treatment techniques used generally result in better outcomes (Izmirian, 
2016; Love, 2014; Orimoto, 2014; Stumpf, Tolman, Mueller, Chorpita, & Daleiden, 2007), and 
that these findings seem to hold for anxiety-related outcomes as well.  Similarly, Southam-
Gerow and colleagues (2010) identified increased treatment and types of treatment in the TAU 
comparison group as a primary reason for the inability to differentiate the effects of CBT from 
usual care in their effectiveness study.  Putting all of this together, a tentative but plausible 
conclusion might be that youth in this sort of system of care might benefit from treatment 
characterized by trying many practices (likely many with low intensity and fidelity by research 
standards) and persisting until something works.   
An interesting exception to the above finding involves the two levels-of-care with the 
highest mean total anxiety progress scores, functional family therapy (mean = 3.85) and 
multisystemic therapy (mean = 3.78).  Divergent from the overall sample, these levels-of-care 
also had the lowest mean proportion of months of anxiety endorsed in treatment and both had 
low rates of exposure use (with exposure never used in functional family therapy and used in 
6% of multisystemic therapy cases).  While these results might suggest family therapy as a 
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potent treatment for anxiety problems, they might also be due to other factors given that (a) 
youth and their families are referred to these levels of care because of disruptive behavior 
problems rather than anxiety (CAMHD, 2012) and (b) meta-analytic research has indicated that 
family involvement in youth anxiety treatment has a non-significant impact on anxiety 
outcomes (Thulin, Svirsky, Serlachius, Andersson, & Öst, 2014).  Although only tentative 
conclusions can be drawn, one possibility is that anxiety problems as conceptualized in the 
context of family treatment for disruptive youth are qualitatively different from those for more 
traditionally anxious youth.  For example, a therapist might target a youth’s initial anxiety or 
fear related to his parents implementing a strict rewards and consequences plan in the home, and 
this anxiety might abate quickly and near-completely as the plan is consistently implemented 
over time.  Another possibility is that these two intervention strategies result in improved 
outcomes across psychological problems due to inherent general factors indicative of high-
quality service delivery (e.g., high quality assurance, frequent therapist supervision, and/or 
intensity of services; Alexander & Robbins, 2011; Denenny & Mueller, 2012).  In partial 
support of this hypothesis, studies of this system of care found that multisystemic therapy 
resulted in improved progress ratings compared to intensive in-home therapy for disruptive 
behavior problems, and demonstrated the quickest and highest level of progress on the treatment 
target of suicide among all levels of care (Denenny & Mueller, 2012; Okado, Wilkie, Jackson, 
& Mueller, 2015).  In light of this, it is noteworthy that the very low mean anxiety progress in 
community-based residential settings when exposure was not used (mean total anxiety progress 
= 2.23) jumped to a level resembling those found in these two high-quality treatment settings 
(mean = 3.50) when exposure was used extensively. 
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When a therapist focused more on externalizing problems (as measured by proportion of 
months in treatment in which externalizing problems were targeted), associated total anxiety 
progress was lower.  This variable’s relationship with anxiety treatment outcomes is likely 
similar to its relationship with exposure use: when anxiety problems receive reduced focus 
compared to other problems, therapists seem to choose different intervention strategies to 
address them and anxiety outcomes might deteriorate slightly as a result.  Specifically, total 
anxiety progress decreased by an estimated mean of 0.19 points as the proportion of 
externalizing months increased from 0 to 1.  Such findings begin to address prior calls for 
research on the relationship between treatment outcomes and disproportionate focus on 
externalizing problems (e.g. Milette-Winfree & Mueller, 2017).  Notably, the present findings 
do not examine treatment progress on other targets, and it might be the case that diminished 
anxiety progress is balanced by enhanced progress on externalizing problems.  At minimum 
these preliminary results warrant a thorough evaluation of the differential effect of externalizing 
treatment focus on both internalizing and externalizing targets. 
Two variables indicative of greater impairment (number of previous episodes and higher 
CAFAS Mood/Emotions score at treatment onset) predicted lower total anxiety progress.   
While these results are somewhat self-evident, they supplement the previously-discussed 
finding that exposure had no discernible effect in the hospital-based treatment setting, where 
youth with the highest levels of emotional impairment were placed.  These three findings seem 
to suggest that, at least in this system of care, there might be certain highly impaired youth who 
are resistant to anxiety treatment in general and exposure treatment in particular.  Whether this 
is due to severity of youth psychopathology, insufficient implementation of exposure, or a 
combination of these and other factors is unclear.  However, the findings seem to suggest that 
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level of impairment should be taken into consideration when therapists decide to commit to 
exposure use or not. 
As in the analysis of exposure utilization, much of the variance in anxiety progress 
between provider agencies was captured by the level-of-care predictor, while therapist-level 
random variance remained unaccounted for by doctorate degree status in this model.  These 
results suggest that other therapist-specific factors contribute to anxiety treatment progress.  
While beyond the scope of the present study, further examination of (a) other practices 
therapists use to treat anxiety, (b) a more complete list of therapist demographic and 
professional characteristics, and (c) therapists’ beliefs and attitudes related to anxiety treatment 
might all be useful in better understanding and accounting for between-therapist variability in 
anxiety outcomes.  
Supplemental analyses indicated that the episode month in which exposure was begun 
had no effect on outcomes.  Notably, Gryczkowski and colleagues (2012) reported faster 
progress for anxiety problems when exposure was started around the second treatment session 
as opposed to the seventh treatment session in an episode.  Unfortunately, the MTPS might not 
be a sufficiently sensitive instrument to discern such fine-grained differences in treatment 
course given it can only examine treatment at the month-to-month level.  Further, exposure was 
endorsed in the first month of treatment in 832 of the 1132 episodes in the sample, resulting in 
most of the cases under study possibly meeting Gryczkowski’s criterion of early endorsement.  
Additionally, in 278 of those 832 episodes in which exposure was used within the first month of 
treatment, exposure was only endorsed once, suggesting early but not sustained use for many 
cases.  Such a short and potentially incomplete exposure effort might be somewhat iatrogenic in 
this system of care, given that at the bivariate level, the mean final progress rating for one 
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month of exposure use was lower than that of no exposure use for three of four anxiety-related 
targets and for the total anxiety progress composite score (see Table 10).  Given the 
questionable quality of exposure endorsed in such limited amounts, this might have further 
confounded these results.  These findings indicate that further research is necessary to confirm 
the enhanced effect of early use of exposure in community mental health. 
Finally, the present findings point to a tentative association between exposure and 
improved treatment progress over time, though significant concerns remain regarding 
exposure’s use and effectiveness in this system of care.  Despite the encouraging findings 
related to the potential effect of exposure therapy reported here, there remain a high number of 
episodes in which exposure use occurred for short durations with no observable impact on 
treatment progress.  Additionally, there is evidence that when exposure is used, it is 
implemented with low quality and/or intensity (Borntrager et al., 2013).  These results are 
sobering given the multi- faceted efforts to promote evidence-based practice use that have been 
ongoing in this system of care since 2008 (Nakamura et al., 2014).  That said, it is also 
noteworthy and encouraging that the subset of episodes that were largely responsible for the 
enhanced outcomes related to exposure in this study (i.e., high usage in community residential 
care) all occurred within the context of these dissemination efforts (episode end date range: 
March 30, 2008 through August 31, 2015).   Further, total anxiety progress increased 
significantly as a function of time at the bivariate level, but this effect was reduced to non- 
significance when examined in the full model, F(1,2711) = 2.91, p = 0.09.  This suggests that 
other factors might be accounting for longitudinal variance in anxiety progress.  It is plausible 
that exposure might be one such factor given its increased utilization over time.  Taken together, 
these results provide tentative correlational evidence of the positive impact of EBP 
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dissemination and implementation efforts in this system of care, though they also indicate that 
much work remains to foster universal high-quality exposure use among treatment providers. 
Implications for Dissemination/Implementation and Systems of Care 
Dissemination and implementation (D&I) efforts have likely been helpful in increasing 
exposure use, but exposure remains an under-used intervention in this system of care, and in a 
majority of episodes under study it had little or no discernible effect on outcomes.  This study 
suggests that future efforts to promote exposure therapy should focus on enhancing both 
utilization and quality of use.  In this system of care, among the few therapists with known 
training, the training for exposure typically occurred over the course of a single half-day 
seminar in which multiple other intervention strategies were also taught (Nakamura et al., 
2014).  Given the previously-reported difficulties therapists have endorsed in implementing 
exposure,  it is likely that many therapists were unable to master its use with such limited 
training.  Notably, a train-the-trainer model of EBP dissemination has also been recently 
implemented in this system of care on a small scale (Nakamura et al., 2014).  One component of 
this model is an emphasis on continual contact between therapists and their supervisors, who 
have been trained in various evidence-based practices and are able to monitor and provide 
feedback related to intervention delivery.  While the impact of this strategy has not yet been 
assessed, such additional oversight and support could be a lynchpin in improving exposure-
associated treatment outcomes.  Indeed, the generally higher levels of anxiety progress in the 
two evidence-based programs, both with structured and ongoing supervision, suggest that such 
dissemination models are needed.  Given that results of this study seem to suggest exposure is 
worth doing if it is done in sufficient amount and when treatment-interfering factors are 
minimized, community therapists could possibly benefit from intensive, longer-term initial 
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trainings and persistent post-training supervision and support to increase the rate of high-
quality, high-duration exposure use in the context of common barriers. 
An important caveat to the above suggestions related to D&I efforts is that there are 
likely cases in which a therapist is presented with an anxiety-related problem and makes the 
thoughtful choice not to engage in exposure therapy, possibly even despite sufficient knowledge 
and competency regarding the practice.  There are at least two reasons this might occur.  As 
previously noted, therapists in this sample are often faced with competing demands, one of 
which is the common occurrence of comorbid externalizing problems.  It is unclear under what 
circumstances therapists should and should not change strategies to shift focus in treatment 
from, for example, delinquent behavior to traumatic stress.  In such cases, it is plausible that an 
externalizing problem is so severe that it should take precedence over an anxiety problem in 
treatment (as suggested earlier with regard to sexual misconduct treatment).  A therapist might 
decide that beginning a course of prolonged exposure would stymy other treatment aimed at 
reducing dangerous or violent behaviors, and therefore might address trauma fleetingly if at all.   
Another plausible situation in which a therapist might thoughtfully choose not to use 
exposure is when an anxiety problem is perceived as relatively minor or fleeting, but still 
worthy of clinical attention.  Evidence indicating that the target of phobias/fears is associated 
with reduced use of exposure provides tentative support for this idea.  Following the previously-
proposed notion that the typical phobias and fears of youth in this system of care might be 
minor or secondary concerns compared to the main reason for referral, such concerns might be 
addressed with other, less resource-intensive interventions (relaxation exercises or coping skill 
development, for example).   An examination of Table 10 and Figure 1 suggests that despite the 
reduced likelihood of therapists using exposure for such cases, the target of phobias/fears 
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actually appears to achieve somewhat higher progress ratings than other anxiety targets.  Tying 
this finding to (a) efficacy research that indicates therapies including exposure are typically 
equivalent but only sometimes superior to other interventions for anxiety problems (e.g., 
Whittal, et al., 2005) and (b) TAU studies that indicate usual care therapists are achieving 
similar or slightly better results on anxiety problems than their CBT-utilizing counterparts (e.g., 
Southam-Gerow et al., 2010), it seems likely that exposure is not always the only solution for 
anxiety-related difficulties.   In such cases, D&I experts might benefit less from pushing a 
potentially unwanted/unneeded intervention upon therapists doing productive work, and instead 
attempting to learn from the successes of these therapists to further advance the D&I field.  All 
this said, further examination of Table 10 indicates that the 4+ months category of exposure 
therapy is associated with approximately a half-point higher mean progress rating on the 
phobias/fears target compared to no exposure use at the bivariate level, suggesting that if 
phobias/fears are pervasive for a youth, exposure remains a promising treatment option. 
Additional system of care implications relate to identifying and addressing barriers to 
effective exposure use.  This study has implicated therapist decisions (e.g., bias toward treating 
externalizing problems), youth impairment (e.g., CAFAS mood/emotions score), and other 
practical concerns (e.g., inconsistent session attendance or low engagement) as likely barriers to 
effective exposure utilization.  Systems of care could therefore potentially benefit from 
enhanced monitoring and assessment of the therapists who use exposure, the youth whom 
exposure is meant to treat, and the environment in which exposure is attempted.  Regarding 
therapist monitoring, at minimum, in this system of care, the simple alteration of the MTPS to 
allow therapists to indicate precisely which practice(s) they use for which targets they endorse 
would improve understanding of the relationship between the problems addressed with 
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exposure and the progress achieved.  In addition to such increased monitoring of exposure 
usage, a valid measure of exposure quality could be utilized periodically to monitor therapists’ 
service delivery, with low scores resulting in remediation that could include additional training 
and supervision. 
 Regarding youth monitoring, recent evidence from this system of care has indicated that 
youth functional impairment as measured by the total CAFAS score is predictive of whether a 
youth will be successfully or unsuccessfully discharged from a given level-of-care (Jackson, 
Hill, Sender, & Mueller, 2016).  Based on the findings here that high anxiety-related 
impairment might limit a youth’s positive exposure outcomes, similar examinations of critical 
levels of impairment above which exposure is contraindicated could advance the field.  Notably, 
the quality of exposure implementation would also need to be taken into account in such an 
analysis in order for results to be meaningful. 
Finally, regarding monitoring of practical/environmental barriers, previous evidence has 
found that an intervention in which a therapist collaboratively elicited and problem-solved 
potential barriers to treatment engagement with parents via a semi-structured interview resulted 
in increased participation in a parent management training program (Nock & Kazdin, 2005).  
System-of-care administrators might benefit from implementing a similar strategy adapted to 
address common exposure barriers prior to the onset of treatment in order to effectively address 
them and maximize treatment engagement and outcomes. 
Limitations 
The findings in this study should be interpreted with caution.  First, reliance on monthly 
retrospective self-report data from therapists can limit confidence in the results.  Although the 
use of self-report is a practical method of studying treatment-as-usual, it is likely less exact than 
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observational coding at identifying subtleties in treatment delivery (Borntrager et al., 2013; 
Garland et al., 2010).  This is particularly true of the MTPS, given it is designed to describe 
treatment across a month rather than at the individual session level.  Further, the fact that 
therapists are the sole source of information for both of the criterion variables and many of the 
major predictor variables in the study creates the possibility of other treatment, therapist, or 
system effects that are driving these findings.  For example, previously-suggested 
organizational pressures related to therapists’ use of evidence-based practices might unduly 
influence how the MTPS is completed in some cases.  Reverse causality is another concern; it 
could be that when any given practice (i.e., exposure) results in treatment progress in one 
month, the therapist will continue to use it for multiple months to continue that progress, 
resulting in enhanced outcomes for those practices used over multiple months compared to 
those used once and discarded.  Future research could examine sequential applications of 
exposure and related anxiety treatment progress to determine whether earlier progress predicted 
later exposure use, and then examine whether other anxiety-related practices exhibit the same 
patterns of progress.  All this said, the psychometric properties of the MTPS have held up 
reasonably well over the past decade, and given the low endorsement rate of exposure in the 
sample overall and the relatively normal distribution of total anxiety progress rating scores, the 
findings presented here do not seem to reflect explicit self-presentation biases on the part of 
therapists, at least regarding use of exposure in treatment. 
A second limitation of this study is its inability to account for high levels of random 
variance between therapists in either their likelihood of using exposure therapy or the extent of 
their progress on anxiety-related problems in treatment.  This is not surprising given the only 
therapist-level variable included in the model (doctoral degree status) was unrelated to either 
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anxiety outcomes or exposure use.  Notably, much of the recent work related to therapists’ 
acceptance and utilization of evidence-based practices has focused on proximal variables such 
as personal beliefs and attitudes about evidence-based practices and perceptions of 
systemic/organizational factors that either promote or discourage their use, though variance 
accounted for by these factors has typically been small (e.g., Becker-Haimes et al., 2017; 
Nakamura et al., 2011).  Future studies that incorporate these or other factors into statistical 
models such as those utilized here might be helpful in better discerning therapist-related 
predictors of exposure use and effectiveness. 
Another set of limitations concerns the four-category variable chosen to reflect exposure 
use in the present study.  First, and related to previously-discussed limitations of the MTPS, this 
variable measures the number of months exposure was endorsed in a treatment episode but does 
not measure the number of episodes or billable hours of exposure within a month.  Considerable 
variance might exist within each exposure use category due to this insensitivity of the 
measurement instrument.  Further, the division of exposure use into categories indicative of 
unequal months of exposure use might have influenced findings.  For example, the 4+ month 
category of exposure use was comprised of a range of four to 70 months of exposure treatment 
across episodes, and this wide range of months was compared to three much narrower 
categories that consisted of zero, one, or two to three months of exposure endorsement.  
However, the slope of anxiety progress as predicted by months of exposure within the 4+ month 
category was non-significant (b = .012, t(331) = .85, p = .40; b = .032, t(330) = 1.82, p = .07 
after 70-month outlier was removed), and a comparison of mean total anxiety progress between 
episodes with two and three months of exposure also resulted in no significant differences 
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(respective means = 2.86 and 3.03, t(371) = -1.08, p = 0.28).  These findings suggest that the 
four group ordinal categorization did not substantially distort findings. 
A final limitation relates to the limited n sizes within several cells when examining the 
interaction between level-of-care and months of exposure use and their relationship to total 
anxiety progress.  As noted in Table 9, 15 out of 32 total cells were comprised of fewer than 10 
treatment episodes.  While this does not violate statistical assumptions (see Method: Data 
Analytic Strategy: Missing data; Cochran, 1952), it limits the ability to interpret potentially 
interesting results.  For example, the extremely few episodes in which exposure was utilized in 
both the sexual misconduct residential treatment and crisis/respite home levels of care had mean 
anxiety progress scores that were lower than those associated with no exposure use in these 
levels of care, but ns within these cells were too small to interpret these findings.  Conversely, 
2-3 months of exposure use appeared related to higher progress ratings in the multisystemic 
therapy level of care compared to other categories of exposure use in that level of care, but only 
seven episodes fell within this category, again rendering such findings difficult to interpret.  
Despite these limitations, the cell indicative of 4+ months of exposure within community-based 
residential treatment contained 64 episodes in the main analysis, which was a sufficient n to 
allow for interpretation of the main findings presented in this study. 
Future Directions 
The findings presented here suggest several areas of future study in addition to those 
suggested earlier.  First, at least two types of replication studies related to exposure use and 
treatment outcomes are needed.  Specifically, an examination of anxiety-related outcomes and 
their association with multiple months of exposure use delivered in another community-based 
setting and/or in a specific residential treatment setting is necessary to verify the findings 
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presented here.   Given literature suggesting gains made in residential treatment are not 
maintained after services end, such a study should also include a follow-up component (e.g., 
Frensch & Cameron, 2002).  Additionally and perhaps more importantly, an analysis of the 
underlying constructs that 4+ months of exposure and residential treatment might represent (i.e., 
high-quality exposure use of sufficient duration while also minimizing pertinent treatment 
barriers) is necessary to determine whether these are indeed the active ingredients that lead to 
more positive outcomes.  Such an analysis, as well as other recommendations described above, 
would necessarily require more sensitive measures of treatment session content than the MTPS, 
as well as valid measures of exposure fidelity and common exposure treatment barriers.  The 
development of such measures would likely be helpful in advancing effectiveness research, 
dissemination and implementation efforts, and the enhancement of system-of-care 
administration. 
Regarding the development of a measure of exposure fidelity, such work might begin by 
adapting the distillation and matching framework utilized by Chorpita and colleagues (2004) to 
discern the common elements across established manualized/modularized exposure 
interventions (recommended dosage; the use of a fear hierarchy to rate anxiety provoking 
situations; debriefing after exposure practice exercises, etc.).  Once the fundamental aspects of 
exposure are discerned, further nuances could then be incorporated as research continues to 
emerge related to enhanced exposure delivery (e.g., by incorporating strategies to increase the 
violation of expectancy during exposure exercises as in Craske, 2014).  Consultation with or 
behavioral analysis of expert exposure practitioners who operate outside of typical research 
contexts could then be undertaken to further enhance the development of this measure.  Such 
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therapists might have unique and useful perspectives on how to adapt exposure treatment to the 
limitations of usual care or other treatment settings. 
Regarding the development of a measure of exposure treatment barriers, there are many 
domains to consider when examining factors that might limit exposure effectiveness.  As 
previously suggested, barriers could be related to the physical environment (e.g., lack of 
transportation or insufficient session time), engagement (e.g., therapists’ reluctance to deliver 
exposure therapy or parents’ ambivalence about ensuring a youth’s attendance in session), 
youth impairment (e.g., highly-pervasive anxiety, comorbid externalizing problems, or other 
psychopathology such as autism or intellectual disability), or other domains.  The development 
of a measure that assesses for such multi-dimensional treatment barriers could help to identify 
cases in which extra effort should be undertaken to deliver exposure therapy, as well as those 
cases in which the likelihood of successful exposure is critically low, thereby suggesting its 
contraindication. 
More broadly, there is a need for far more treatment-as-usual research that is conducted 
independently of other treatment studies, taking care to avoid common pitfalls of usual-care 
research (e.g., artificially constraining TAU services in order to accommodate a comparison 
treatment group as in Southam-Gerow et al., 2010) and resulting in a more thoughtful and 
unbiased examination of usual care services.  Given demands for increased accountability of 
health services, the opportunity seems ripe for the development, implementation and analysis of 
data tracking methods in addition to those described above that will likely both improve mental 
health service and advance treatment-as-usual research.  One worthwhile object of such data 
tracking might be the number and type of practices usual care therapists use in treatment, given 
this study joins several others in this system of care in suggesting that the application of more 
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and more varied practices predicts better treatment progress (e.g., Izmirian, 2016).  Such 
findings suggest that the mechanism of improvement and the choices being made by therapists 
might be quite different from those presumed by efficacy researchers and evidence-based 
practice experts.  Further practice based research can begin to address such issues and bring a 
better balance to the research-practice bridge. 
Another area of future research involves the examination of therapist factors that 
influence exposure use, given current analyses failed to account for therapist variance in 
exposure use or anxiety progress.  Notably, on a recently-developed questionnaire measuring 
therapists’ beliefs about exposure, high scores (indicative of more negative beliefs) predicted 
limited endorsement of exposure use in a clinical vignette (Deacon et al., 2013).  Such a 
questionnaire could be incorporated into future studies in this system of care to elucidate 
therapist factors contributing to exposure use.  That said, the questionnaire’s exclusive 
examination of therapists’ negative beliefs related to exposure could substantially limit findings, 
given it does not offer the opportunity for a therapist to explain what he or she might choose to 
do instead of exposure, and might further imply that it is wrong to use interventions other than 
exposure for anxiety-related problems.  Therefore, future examinations of therapist decisions 
when confronted with anxiety problems might benefit from taking a more open-ended approach 
in order to elicit a wider range of responses and to better ascertain the potentially effective 
practices other than exposure that usual care therapists are employing. 
Finally, further consideration of agency-specific effects related to exposure use and 
anxiety-related treatment progress could advance the field.  While the level-of-care predictor 
variable accounted for significant between-agency variance in both exposure use and anxiety 
treatment progress, significant random variance between agencies remained in both analyses.  
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Given that these agencies are organizations of diverse size, operating in diverse locations (e.g., 
across various islands and in both urban and rural settings), and prioritizing a variety of 
leadership, training, and service delivery prerogatives (Nakamura et al., 2011), future analyses 
of such characteristics could be helpful in identifying key organizational traits that impact 
exposure use and anxiety outcomes specifically, and evidence-based practice delivery and 
overall treatment outcomes more broadly. 
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Table 1. Characteristics of youth treated for anxiety-related problems (n = 3511). 
 Total Sample 
Mean age (SD) at first episode start 13.7(3.4) 
Count (%) of sex 
 
     Male 2169(61.8) 
     Female 1342(38.2) 
Count (%) of race: 
 
     Not Available 294(8.4) 
     American Indian 18(0.5) 
     Asian 273(7.8) 
     Black or African-American 52(1.5) 
     Native Hawaiian and Pacific Islander 369(10.5) 
     White or Caucasian 472(13.4) 
     Other Race or Ethnicity 31(0.9) 
     Multiracial 1999(57.0) 
Count (%) of primary diagnosis at first episode:  
     Disruptive behavior 1085(31.0) 
     Depressive disorder 521(10.9) 
     Bipolar/Mood disorder 169(6.0) 
     ADHD 536(14.4) 
     Thought disorder 70(2.4) 
     Anxiety/Trauma/OCD 451(14.4) 
     Adjustment disorder 268(5.2) 
     Substance use disorder 139(6.1) 
     Other diagnosis 272(4.9) 
Count (%) of any anxiety diagnosis in any episode:  1005(28.6) 
Mean (SD) number of treatment episodes 2.85(2.72) 
Note. Percentages within Total Sample column reflect the percentage of the total 
sample with a given sex, race, or primary diagnosis. ADHD = Attention 
Deficit/Hyperactivity Disorder, all subtypes. OCD = Obsessive-Compulsive 
Disorder.  
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Table 2. Treatment episodes with one or more anxiety-related target (k = 6616). 
  Total Sample 
Mean (SD) length of episode in days  200.0(221.7) 
Mean start date of episode 10/16/2010 
Mean (SD) number of MTPSs per episode 7.81(7.21) 
Mean (SD) of the following treatment characteristics:  
    Proportion of episode months in which anxiety targets endorsed 0.69(0.34) 
    Mean number of practices endorsed per month 16.7(9.9) 
    CAFAS Mood Subscale Score 17.9(7.1) 
Count (%) of episodes in which the following targets were endorsed:  
     Anxiety 3636(54.9) 
     Avoidance 2231(33.7) 
     Phobias or Fears 3469(52.4) 
     Traumatic Stress 1480(22.4) 
Mean (SD) final progress rating for the following anxiety targets:  
     Anxiety 3.0(1.5) 
     Avoidance 2.5(1.6) 
     Phobias or Fears 3.1(1.6) 
     Traumatic Stress 2.7(1.5) 
     Total Anxiety Progress 2.9(1.5) 
Count (%) of episodes in the following levels-of-care:  
    Hospital-based services 517(7.8) 
    Sexual misconduct residential treatment 82(1.2) 
    Respite/Crisis home 323(4.9) 
    Community-based residential treatment 972(14.7) 
    Therapeutic foster care 1028(15.5) 
    Multisystemic therapy 379(5.7) 
    Functional family therapy 113(1.7) 
    Outpatient services 119(1.8) 
    Intensive in-home therapy 3083(46.6) 
Note. Percentages within Total Sample column reflect the percentage of the total 
sample with the characteristic in the corresponding row.  
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Table 3. Therapists’ highest degree (n = 655). 
 Count (%) of Therapists 
Total doctorate level therapists: 63 (9.6) 
Clinical Doctorate of Philosophy (Ph.D.) 12 (1.8) 
Doctorate of Psychology (Psy.D.) 26 (4.0) 
Medical Doctor (M.D.) 16 (2.4) 
Other doctorate 9 (1.4) 
Total non-doctorate level therapists : 588 (89.8) 
Counseling/psychology/therapy-related Master’s degree 351 (53.6) 
Master’s degree in social work 159 (24.3) 
Other Master’s degree 41 (6.3) 
Bachelor’s degree 29 (4.4) 
High school graduate 8 (1.2) 
Other/unspecified degree: 4 (0.6) 
Note. Percentages within Total Sample column reflect the percentage of the total 
sample with the characteristic in the corresponding row.  
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Table 4. Agencies grouped by level-of-care (n = 83). 
 Count (%) of agencies 
Hospital-Based Services 5 (6.0) 
Sexual Misconduct  Residential Treatment 3 (3.6) 
Respite/Crisis Home 10 (12.0) 
Community-Based Residential Treatment 7 (8.4) 
Therapeutic Foster Care 24 (28.9) 
Multisystemic Therapy 6 (7.2) 
Functional Family Therapy 3 (3.6) 
Outpatient Services 8 (9.6) 
Intensive In-Home 17 (20.5) 
Note. Percentages within Total Sample column reflect the percentage of the total 
sample with the characteristic in the corresponding row.  
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Table 5. Significant predictors of exposure use likelihood across treatment episodes (k = 5682). 
 Fixed Effects 
B S.E. T Df Sig. 
Odds 
Ratio 
95% C.I. for Odds Ratio 
Lower Upper 
 Intercept -5.55 0.75 -7.37 23 <0.001 0.004 0.001 0.02 
 Episode end date1 0.03 0.01 2.37 1 0.02 1.03 1.01 1.06 
 Proportion of months of 
externalizing treatment in episode 
-0.91 0.15 -5.88 1 <0.001 0.40 0.30 0.55 
  Total episode months 0.09 0.08 11.13 1 <0.001 1.09 1.07 1.11 
 Mean number of unique practices 
used per month 
0.10 0.01 12.17 1 <0.001 1.10 1.09 1.12 
 CAFAS Mood/Emotions score at 
treatment onset 
0.02 0.01 2.41 1 0.02 1.02 1.003 1.03 
 Number of unique anxiety targets 
identified for treatment 
0.26 0.07 3.78 1 <0.001 1.30 1.14 1.49 
 Proportion of months of anxiety 
treatment in episode  
0.55 0.19 2.87 1 <0.001 1.74 1.19 2.54 
 Presence of an anxiety disorder 
diagnosis2 
0.28 0.11 2.61 1 0.01 1.32 1.07 1.62 
 Fears/phobias targeted in 
treatment2 
-0.31 0.12 -2.67 1 0.01 0.73 0.59 0.92 
 Level of care = Sexual misconduct 
residential treatment3 
-3.15 1.20 -2.62 8 0.01 0.04 0.004 0.45 
 Level of care = Crisis/Respite 
home3 
-2.94 1.14 -2.57 8 0.01 0.05 0.006 0.50 
 Youth race = Asian2 0.45 0.18 2.50 1 0.01 1.56 1.10 2.20 
 Youth received exposure in a 
previous episode2 
0.39 0.13 3.04 1 0.002 1.47 1.15 1.88 
Random Effects estimate S.E. Z-score  Sig.  Lower Upper 
 Agency 0.80 0.30 2.68  0.01  0.38 1.65 
 Therapist 2.02 0.24 8.54  <0.001  1.60 2.54 
Note. 1Episode end date is measured in six-month-long intervals beginning on July 1, 2006.  2Dichotomous variable, 1= 
true/yes, 0 = false/no.  3These two categories of level-of-care are compared to the reference category of hospital-based care 
(which had the highest proportion of exposure use among all levels-of-care).  Likelihood of exposure use did not differ 
between hospital-based services and any other level-of-care, therefore other levels-of-care are not reported.  CAFAS = Child 
and Adolescent Functional Assessment Scale.  Significant predictors in the model are in bold-face. Other non-significant 
factors in the model not displayed in the table are: therapist doctorate degree, t = -.35, p=.75; number of previous treatment 
episodes, t = -.85, p=.39, youth sex, t = .51, p=.61 and youth age at episode onset, t = .05, p=.47. 
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Table 6. Significant predictors of total anxiety progress across treatment episodes, main effects 
model (k = 5682). 
  
Fixed Effects 
B S.E. T Df Sig. 
95% C.I. for Odds 
Lower Upper 
 Intercept -6.29 0.62 15.59 1 <0.001 1.33 2.41 
 No exposure use1 -0.37 0.09 -3.89 3 <0.001 -0.55 -0.18 
 One month of exposure1 -0.32 0.11 -3.02 3 0.003 -0.53 -0.11 
 2-3 months of exposure1 -0.25 0.11 -2.23 3 0.03 -0.46 -0.03 
 Total episode months 0.04 0.003 14.23 1 <0.001 0.04 0.05 
 Mean practices used per month 0.03 0.003 8.68 1 <0.001 0.02 0.04 
 Proportion of months of externalizing 
treatment in episode 
-0.19 0.06 -3.20 1 0.001 -0.31 -0.07 
 Proportion of months of anxiety 
treatment in episode  
0.43 0.72 6.03 1 <0.001 0.29 0.58 
 CAFAS Mood/Emotions score at 
treatment onset 
-0.01 0.003 -3.67 1 <0.001 -0.02 -0.005 
 Number of previous treatment 
episodes 
-0.03 0.007 -4.83 1 <0.001 -0.05 -0.02 
 Level of care = Hospital-based2 0.46 0.24 1.90 8 0.07 -0.03 0.96 
 Level of care = Sexual misconduct residential2 0.58 0.31 1.88 8 0.07 -0.04 1.20 
  Level of care = Crisis/respite home2 0.74 0.21 3.44 8 0.001 0.30 1.17 
 Level of care = Therapeutic foster2 0.44 0.16 2.69 8 0.01 0.11 0.77 
 Level of care = MST3 1.31 0.21 6.21 8 <0.001 0.88 1.74 
 Level of care = FFT2 1.38 0.30 4.67 8 <0.001 0.79 1.98 
 Level of care = Intensive in-home 0.52 0.17 3.02 8 0.005 0.17 0.88 
 Level of care = Other outpatient 1.05 0.25 3.89 8 <0.001 0.55 1.56 
Note. 1These categories of exposure use are compared here to the reference category of 4+ months of exposure use.  
2These categories of level-of-care are compared to the reference category of community-based residential treatment, 
which had the lowest mean total anxiety progress among all levels-of-care.  CAFAS = Child and Adolescent 
Functional Assessment Scale. MST = Multisystemic Therapy. FFT = Functional Family Therapy. Other non-
significant factors in the model not displayed in the table are: episode end date, F(1,2714)=2.34, p = .13; therapist 
doctorate degree, F (1,471)= .81, p=.37; youth sex, F (1,2397)= 1.92, p=.17; youth anxiety diagnosis, F(1,3682)= 
1.349, p=.22; youth race, F(7,2394)=1.03 p=.41; and youth age, F(1,3430)=.06, p=.81. Random effects in this model 
are identical to those in Table 8, therefore they are not reported here. 
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Table 7. Mean total anxiety progress for exposure use and level-of-care categories, main effects 
model. 
Exposure Use 
Mean Total 
Anxiety Progress Std. Error 
0 months 3.05 0.09 
1 month 3.10 0.11 
2-3 months 3.18 0.12 
4+ months 3.42 0.13 
Level of Care 
Mean Total 
Anxiety Progress Std. Error 
Community-based 
residential treatment 2.47 0.16 
Hospital-based services 
2.93 0.21 
Sexual misconduct 
residential treatment 3.05 0.29 
Crisis/respite home 
3.21 0.18 
Intensive in-home 2.99 0.12 
Therapeutic foster care 
2.91 0.12 
Multisystemic therapy 
3.78 0.18 
Functional family 
therapy 3.85 0.27 
Other outpatient services 
3.53 0.22 
Note. “Mean” values in this table reflect estimated marginal means generated  
via the main effect model described in Table 6. 
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Table 8. Significant predictors of total anxiety progress, including interaction between exposure 
and level-of-care, across treatment episodes, (k = 5682). 
 Fixed Effects 
B S.E. t Df Sig. 
95% C.I. for Odds 
Lower Upper 
 Intercept 2.59 0.30 8.63 1 <0.001 2.00 3.18 
 No exposure x residential treatment1 -1.27 0.18 -7.14 16 <0.001 -1.62 -0.92 
 1 month exposure x residential treatment1 -0.97 0.22 -4.49 16 <0.001 -1.39 -0.55 
 2-3 months exposure x residential treatment1 -1.03 0.21 -4.81 16 <0.001 -1.45 -0.61 
  Total episode months 0.04 0.003 14.46 1 <0.001 0.04 0.05 
 Mean number of unique practices used per month 0.03 0.003 8.62 1 <0.001 0.02 0.04 
 Proportion of months of externalizing 
treatment in episode 
-0.19 0.06 -3.11 1 0.002 -0.31 -0.07 
 Proportion of months of anxiety 
treatment in episode  
0.45 0.07 6.19 1 <0.001 0.31 0.59 
 CAFAS Mood/Emotions score at 
treatment onset 
-0.01 0.003 -3.60 1 <0.001 -0.01 -0.004 
 Number of previous treatment 
episodes 
-0.03 0.01 -4.93 1 <0.001 -0.05 -0.02 
Random Effects Estimate S.E. Wald Z  Sig.   
 Youth 0.14 0.03 4.32  <0.001 0.09 0.22 
 Clinician 0.33 0.04 9.16  <0.001 0.27 0.41 
 Agency 0.07 0.03 2.06  0.04 0.03 0.17 
Note.1These interactions of exposure and level-of-care are compared to the reference interaction of 4+ 
months of exposure and community-based residential treatment. Other interaction effects are not 
presented here. 2Episode end date is measured in six-month intervals beginning on July 1, 2006. CAFAS 
= Child and Adolescent Functional Assessment Scale. Given the significant interaction between exposure 
use and level-of-care, individual effects for each of these variables are not interpretable and therefore not 
reported here. Other non-significant factors in the model not displayed in the table are: episode end date, 
F(1,2711)=2.91, p=.09, therapist doctorate degree, F(1,474)= .90, p=.34; youth sex, F(1,2414)=2.14, 
p=.14; youth anxiety diagnosis, F(1,3658)= 1.33, p=.25; youth race, F(1,2395)=1.03, p=.41; and youth 
age, F(1,2814)=.02, p=.88. 
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Table 9. Number of episodes and mean total anxiety progress for exposure use by level-of-care 
interactions in main analysis (k = 5682). 
Level of Care Exposure Use 
Number of 
Episodes 
Mean Total Anxiety 
Progress Std. Error 
Community-based residential 
treatment 
0 months 630 2.23 0.16 
1 month 90 2.53 0.21 
2-3 months 89 2.46 0.22 
4+ months 64 3.50 0.23 
Hospital-based services 0 months 282 2.84 0.22 
1 month 84 2.82 0.25 
2-3 months 63 2.79 0.27 
4+ months 15 2.68 0.40 
Sexual misconduct residential 
treatment 
0 months 64 2.99 0.30 
1 month 2 2.08 0.96 
2-3 months 0 N/A N/A 
4+ months 0 N/A N/A 
Crisis/respite home 0 months 249 3.09 0.18 
1 month 2 2.77 0.94 
2-3 months 0 N/A N/A 
4+ months 0 N/A N/A 
Intensive in-home 0 months 2068 2.88 0.12 
1 month 202 2.88 0.15 
2-3 months 125 2.89 0.17 
4+ months 179 3.04 0.16 
Therapeutic foster care 0 months 811 2.80 0.11 
1 month 46 2.48 0.23 
2-3 months 35 3.11 0.25 
4+ months 35 2.64 0.26 
Multisystemic therapy 0 months 314 3.65 0.18 
1 month 6 3.95 0.54 
2-3 months 7 4.66 0.56 
4+ months 6 3.26 0.59 
Functional family therapy 0 months 108 3.71 0.27 
1 month 0 N/A N/A 
2-3 months 0 N/A N/A 
4+ months 0 N/A N/A 
Other outpatient services 0 months 99 3.41 0.22 
1 month 5 4.05 0.62 
2-3 months 0 N/A N/A 
4+ months 1 1.11 N/A 
Note. N/A indicates no total anxiety progress score statistics could be calculated because there were no observed 
values within these cells. “Mean” values in this table reflect estimated marginal means generated via the interaction 
effect model described in Table 8. 
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Table 10. Mean final progress rating for each anxiety-related target per exposure use category 
across all treatment episodes (k = 6616). 
Anxiety 
Exposure Use Mean Progress Rating 
0 Months 2.96 
1 Month 3.06 
2-3 Months 3.16 
4+ Months 3.64 
 
Phobias or Fears 
Exposure Use Mean Progress Rating 
0 Months 3.12 
1 Month 2.89 
2-3 Months 2.90 
4+ Months 3.63 
 
Traumatic Stress 
Exposure Use Mean Progress Rating 
0 Months 2.64 
1 Month 2.42 
2-3 Months 2.70 
4+ Months 3.22 
 
Avoidance 
Exposure Use Mean Progress Rating 
0 Months 2.42 
1 Month 2.55 
2-3 Months 2.79 
4+ Months 3.42 
 
Total Anxiety Progress 
Exposure Use Mean Progress Rating 
0 Months 2.86 
1 Month 2.81 
2-3 Months 2.93 
4+ Months 3.54 
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Figure 1. Final progress ratings across anxiety-related treatment targets and total progress score 
for all treatment episodes (k = 6616). 
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Appendix A: Level of Care Descriptors* 
Level of Care Service Categories within 
Level of Care (n of 
episodes in dataset) 
Description of Service Category 
Hospital-Based 
Services 
Hospital-based Residential 
Care (450) 
Intensive, psychiatric and nursing treatment in a 24/7 
locked facility for youth with severe behavioral health 
conditions requiring immediate symptom stabilization. 
Partial Hospitalization (67) 
Time-limited, non-residential day treatment for youth 
with serious emotional disturbances, intended to keep 
youth with family/community. Provides transitional 
services for youth who no longer require intensive 
supervision. 
Sexual Misconduct 
Residential 
Treatment 
Residential Sex Offender 
Program (47) 
Treatment and small group living in a 24-hour locked 
care facility for youth with sexually aggressive or 
deviant offending behavior who pose a high risk to the 
community. 
High-Security Residential 
Care (35) 
Treatment and 24 hour care in a small, secured group 
setting for youth with behavioral and emotional 
problems related to sexual offending, aggression, or 
deviance who pose a moderate risk to the community. 
Respite/Crisis 
Home 
Therapeutic Respite Home 
(87) 
Short term (typically <48 hours) care/supervision in a 
transitional home setting for youth with 
emotional/behavioral challenges to prevent disruptions 
in the regular living arrangement 
Therapeutic Crisis Home 
(182) 
Short-term, 24/7 crisis stabilization services for youth 
with urgent/emergent mental health needs and without 
the need for treatment in a psychiatric setting. 
Community Mental Health 
Shelter (54) 
Temporary (24 hour) care by trained professional and 
paraprofessional staff for youth awaiting treatment 
facility placement. 
Community-Based 
Residential 
Treatment 
Community-Based 
Residential Sservices (972) 
24/7 treatment/supervision for youth with behavioral, 
emotional and/or family problems. Program structure 
includes onsite education, diagnostic, and treatment 
services not available in the community.  
Therapeutic Foster 
Care 
Therapeutic Group Home 
(238) 
24 hour care by trained professional and 
paraprofessional staff for youth in need of a structured, 
small group, community-based setting. 
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Transitional Family Home 
(746) 
Intensive, short term treatment (6-8 months or 1-3 
months for crisis stabilization) for youth with 
emotional/behavioral challenges intended to reunite 
youth with family or other longer term family home. 
May be used to transition youth from more restrictive 
placements. 
Multidimensional 
Therapeutic Foster Care (44) 
Intensive treatment provided in a foster family setting 
for youth with delinquent and/or disruptive behaviors 
and emotional challenges. Prepares aftercare resources 
(parents, relatives, etc.) for youth’s return. 
Multisystemic 
Therapy 
Multisystemic Therapy 
(379) 
Manualized, time-limited (~5 months), 
family/community-based treatment for juvenile 
offenders with serious anti-social behavior, targeting 
behavior change in youth’s natural environment  
Functional Family 
Therapy 
Functional Family Therapy 
(113) 
Manualized family-based treatment (3-6 months) in a 
home or clinic setting consisting of 8-12 one-hour 
sessions and up to 30 hours of direct services for youth 
experiencing externalizing behavior disorders, family 
problems, and often an additional co-morbid 
internalizing behavioral/emotional problem. 
Intensive In-Home Intensive In-Home (3087) 
Youth-and family-centered interventions in the youth’s 
current living environment, targeting identified 
treatment outcomes with approved evidence based 
practices.  
Outpatient Services 
Medication Management (4) 
Ongoing assessment of youth’s response to med ication, 
symptom management, side effects, adjustment and/or 
change in medication and in medication dosage 
provided by a certified psychiatrist or licensed nurse.  
Outpatient therapy (115) 
Regularly-scheduled outpatient face-to-face individual, 
group, or family therapeutic services that do not fall 
within any of the above categories . 
*These summaries are derived from Hawaii Department of Health (2012) and Hawaii Departments of Education 
and Health (200 
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Appendix B: Monthly Treatment and Progress Summary (MTPS) Form (2008) 
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Appendix C: Monthly Treatment Progress Summary (2008) Instructions and Codebook 
 
97 
 
 
98 
 
 
99 
 
 
100 
 
 
101 
 
 
102 
 
 
103 
 
104 
 
 
105 
 
 
106 
 
 
107 
 
 
108 
 
Appendix D: Child and Adolescent Functional Assessment Scale  
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Appendix E: Child and Adolescent Mental Health Division Notice of Privacy Practices 
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Appendix F: Further Discussion of Data Analytic Plan 
Testing statistical modeling assumptions.  Various assumptions of multi- level modeling 
were considered to ascertain the appropriateness of the data analytic plan.  First, the assumption 
that residual variance in the criterion variable be normally distributed was examined.  Regarding 
Analysis 1 (predicting exposure use), this assumption does not apply to binomial logistic 
regression analyses, given the variable is transformed to fit a binomial distribution with fixed 
error variance at the episode level of analysis (Heck, Thomas, & Tabata, 2012).   Regarding 
Analysis 2 (predicting anxiety treatment progress), this assumption does apply, and the 
distribution of the criterion variable (total anxiety progress) violated the Kolmogorov-Smirnov 
test of normality (p<.001).  However, as seen in Figure 1, the distribution of this variable 
resembles a normal curve, and the distribution of residual variance in this variable when 
examined at the episode level was normal.  Next, the assumption that higher- level 
classifications must account for significant random variance in the criterion variable in order to 
be included in a cross-classified model was considered (Heck et al., 2013).  The variance 
accounted for by random youth, therapist, and agency factors was examined for the criterion 
variables in both analyses.  For Analysis 1 (predicting exposure use), preliminary analysis of a 
null cross-classified model indicated that the likelihood of exposure use varied significantly as a 
function of random therapist (variance parameter estimate = 1.81, Intra-class correlation [ICC] 
= .355, p < .001) and agency (variance parameter estimate = 1.42, ICC = .301, p < .001) effects, 
but not youth effects (ICC= .016, p = .17).  These results suggest that approximately 35.5%, 
30.1%, and 1.6% of the random variance in likelihood of exposure use is accounted for by 
therapist, agency, and youth effects, respectively.  As such, youth effects did not appear to 
significantly influence likelihood of exposure use, and therefore the youth-level category was 
removed from the cross-classified model in Analysis 1.  Youth-level variables (i.e, race and 
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gender) were consequently examined at the episode-level in this analysis.  Regarding Analysis 2 
(predicting anxiety treatment progress), all three higher- level classifications in the analysis 
accounted for a significant percentage of estimated random variance in total anxiety progress in 
the null model (youth: 9.2%, therapist: 14.5%, agency: 5.8%; respective variance parameter 
estimates = 0.211, 0.331, and 0.133, all ps <.01), and so were retained for the main analysis.  
There was no evidence of multicollinearity between predictor variables in either Analysis 1 or 
Analysis 2. 
Analytic procedure. Heck et al. (2013), Peugh (2010), and Fielding & Goldstein (2006) 
note the following steps needed to conduct a multi- level analysis and describe how they can be 
applied to cross-classified analyses.  In addition to the ICC calculations and descriptive analyses 
noted in Data Preparation, the restricted estimation maximum likelihood [REML] of parameter 
estimation was selected due to its tendency to lead to better estimates when there are a smaller 
number of groups in a study and to increase expediency of analysis (Heck et al., 2013).  Scaling 
of one variable (episode end date) was performed to provide for easier interpretation of the data 
(see Method: Data Analytic Strategy for details; Heck et al., 2013).  
The current study examined whether recency of treatment episode, therapist education 
level, comorbid externalizing problems, or other factors predicted the use/non-use of exposure 
therapy (Analysis 1) and whether exposure use predicted enhanced therapist-reported progress 
ratings (Analysis 2) after holding other variables constant for children receiving treatment for 
anxiety-related problems.  The classifications under consideration consisted of a level one 
variable reflecting treatment episode, and cross-classified higher level variables reflecting 
youth, therapist and provider agency.  The episode level included several of the main predictor 
variables of interest for both analyses.  In Analysis 1 (predicting exposure use), proportion of 
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months in treatment in which externalizing problems were targeted and episode end date were 
examined at this level, along with several episode-level covariates (e.g., anxiety diagnoses and 
episode length).  In Analysis 2, the main predictor variable of interest (months of exposure use) 
was also examined at the episode level while also accounting for other episode-level covariates.  
In Analysis 1, the higher-order classifications controlled for random between-therapist and 
between-agency variation.  Highest degree earned was examined at the therapist level, and 
level-of-care was examined at the agency level.  In Analysis 2, the higher-order classifications 
controlled for random between-youth, between-therapist, and between-agency variation.  Youth 
sex and race were examined at the youth level, highest degree earned was examined at the 
therapist level, and level-of-care was examined at the agency level. 
Below are the equations that represent the two multilevel models for the current study 
using Browne, Goldstein, & Rasbash’s (2001) classification scheme.  Models 1 and 2 
correspond respectively with Analyses 1 and 2 noted above.  The variables with the coefficient 
u represent the random effect of the cross-classification notated in the subscript of each variable. 
The number in parentheses indicates a separate higher-order random effect and the parentheses 
surrounding i indicate that individuals (i.e., episodes) are nested within the higher-order 
classification. Classification 1 is the identity classification, which applies to the lowest level 
(episode), and is typically not included (Brown et al., 2001).  More specifica lly, in the first 
analysis, the equation includes the higher-order random effects of agency (𝑢
𝑎𝑔𝑒𝑛𝑐𝑦(𝑖)
(3)
) and 
clinician (𝑢
𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛(𝑖)
(2)
), but not youth, given the absence of significant random variability in 
likelihood of exposure use between youth.  The equation for Analysis 2 includes the higher-
order categories of agency (𝑢0𝑎𝑔𝑒𝑛𝑐𝑦(𝑖)
(4)
), clinician (𝑢0𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛(𝑖)
(3) ), and youth (𝑢0𝑦𝑜𝑢𝑡ℎ(𝑖)
(2)
), as all 
three categories accounted for significant random variance in the null model. 
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Model variables. The variables included in the model are as follows: 
Outcome variable (Model 1): ηi = log odds of exposure utilization in a given episode, as 
calculated by the equation ln(
𝜋𝑖
1−𝜋𝑖
), where π represents the probability of exposure use 
for episode i 
Outcome variable (Model 2): yi = total anxiety progress in a given episode 
Predictor variables: 
enddate: six-month time interval in which a treatment episode ended 
uniquetargets: the mean number of unique anxiety targets endorsed per month in a 
treatment episode 
anxtargets: the proportion of months within an episode in which at least one anxiety-
related target was endorsed 
exttargets: the proportion of months within an episode in which at least one 
externalizing target was endorsed 
prevepisodes: number of youth’s previous treatment episodes 
prevexpYN: whether or not a youth received exposure in a prior treatment episode 
practices: mean number of unique practices/intervention strategies endorsed per 
treatment month 
CAFASMood: score on the CAFAS Mood/Emotions subscale at start of treatment 
episode 
months: length of episode in months 
age: age of youth at start of episode 
sex: sex of youth 
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race: race of youth (see Table 2 for race categories). For Analysis 1, preliminary 
bivariate analyses indicated youth identified as Asian were more likely to receive 
exposure therapy than other youth, and there were no other significant differences across 
other race classifications apart from the ‘race not availab le’ category’s association with 
reduced likelihood of exposure treatment. Because this finding could not be interpreted, 
it was not included in the model.  Therefore race in Model 1 is a dichotomous variable 
reflecting whether or not a youth was identified as Asian.  Given that preliminary 
analyses of variance found no differences in total anxiety progress between racial 
categories, in Model 2, race is measured as a categorical variable reflective of the eight 
race categories described in Table 2. 
doctorYN: whether or not the clinician had a doctorate degree 
levelofcare: the level-of-care in which an agency provided services 
exp: the number of months in which a clinician used exposure therapy in an episode, 
broken into four categories (0 months of exposure, 1 month of exposure, 2-3 months of 
exposure, 4+ months of exposure). 
Model 1: Predicting use of exposure when anxiety-related targets are present 
𝜂i= ln(
𝜋𝑖
1−𝜋𝑖
) =βo+β1𝑒𝑛𝑑𝑑𝑎𝑡𝑒𝑖 + β2𝑢𝑛𝑖𝑞𝑢𝑒𝑡𝑎𝑟𝑔𝑒𝑡𝑠i+ β3anxtargetsi+ β4exttargetsI   
+β5prevepisodesi + β6prevexpYNi + β7practicesi + β8CAFASMoodi+β9monthsi  
+β10𝑎𝑔𝑒i+β11𝑠𝑒𝑥𝑖+β12𝑟𝑎𝑐𝑒𝑖 + β13𝑑𝑜𝑐𝑡𝑜𝑟𝑌𝑁𝑖
(2)
 +  β14𝑙𝑒𝑣𝑒𝑙𝑜𝑓𝑐𝑎𝑟𝑒𝑖
(3)
+𝑢𝑎𝑔𝑒𝑛𝑐𝑦(𝑖)
(3)
+𝑢𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛(𝑖)
(2)
 
In Model 1, ηi represents the log odds of exposure being utilized in any given episode.  
β0 reflects the log odds of exposure use across all agencies and clinicians when fixed effects are 
held to a constant value.  Note that because the outcome is dichotomous, there is no separate 
residual variance at level 1 (i.e., for a logistic distribution, it is fixed at 
𝜋2
3
or about 3.29)  The 
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random variances for the higher-order classifications of agency and clinicians are assumed to be 
normally distributed with mean of zero and variance 𝜎𝑢(3)
2  and 𝜎𝑢(2)
2 , respectively.  In this model, 
the β coefficients represent fixed effects of each predictor on the outcome. Those variables with 
β coefficients and no superscript classification numbers are fixed effects corresponding to the 
classification-1 (episode) level. Beta coefficients with superscripts 2 (𝑑𝑜𝑐𝑡𝑜𝑟𝑌𝑁𝑖
(2)
) and 3 
(𝑙𝑒𝑣𝑒𝑙𝑜𝑓𝑐𝑎𝑟𝑒𝑖
(3)
) indicate predictors associated with those higher-order classifications.  
Model 2: Predicting anxiety-related improvement as a function of the use of exposure  
y
i
=β
o
+β
1
exp
i
+ β
2
enddatei+ β3anxtargetsi+ β4exttargetsi +β5prevepisodesi+ β6practicesi + 
 β7CAFASMoodi+ β8monthsi+ β9𝑎𝑔𝑒i+ β10𝑠𝑒𝑥𝑖
(2)
 +  β11𝑟𝑎𝑐𝑒𝑖
(2)
+ β12𝑑𝑜𝑐𝑡𝑜𝑟𝑌𝑁𝑖
(3)
 
 +  β13𝑙𝑒𝑣𝑒𝑙𝑜𝑓𝑐𝑎𝑟𝑒𝑖
(4)
+𝑢0𝑎𝑔𝑒𝑛𝑐𝑦(𝑖)
(4)
+𝑢0𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛(𝑖)
(3)
+𝑢0𝑦𝑜𝑢𝑡ℎ(𝑖)
(2)
+εi 
In Model 2, yi represents the mean total anxiety progress rating across all episodes, β0 
reflects the mean total progress rating across all agencies, clinicians, and youth when fixed 
effects are held to a constant value, and εi represents the remaining unexplained episode-level 
variance in anxiety progress. The random variances for the higher-order classifications of 
agency, clinician, and youth are assumed to be normally distributed with mean of zero and 
variance 𝜎𝑢(4)
2 , 𝜎𝑢(3)
2 , and 𝜎𝑢(2)
2 . The level-1 residual variance is also assumed to be normally 
distributed with mean of zero and variance 𝜎𝑒
2. As noted in Results, this model was run again to 
test for a significant interaction between the levelofcare and exp variables. This equation is 
identical to the one above, with the exception of the added interaction term, and is represented 
as follows: 
y
i
=β
o
+β
1
exp
i
+ β
2
enddatei+ β3anxtargetsi+ β4exttargetsi +β5prevepisodesi+ β6practicesi + 
 β7CAFASMoodi+ β8monthsi+ β9𝑎𝑔𝑒i+ β10𝑠𝑒𝑥𝑖
(2)
 +  β11𝑟𝑎𝑐𝑒𝑖
(2)
+ β12𝑑𝑜𝑐𝑡𝑜𝑟𝑌𝑁𝑖
(3)
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 +  β13𝑙𝑒𝑣𝑒𝑙𝑜𝑓𝑐𝑎𝑟𝑒𝑖
(4)
 +  β14expi ∗ 𝑙𝑒𝑣𝑒𝑙𝑜𝑓𝑐𝑎𝑟𝑒𝑖
(4)
+𝑢0𝑎𝑔𝑒𝑛𝑐𝑦(𝑖)
(4)
+𝑢0𝑐𝑙𝑖𝑛𝑖𝑐𝑖𝑎𝑛(𝑖)
(3)
+𝑢0𝑦𝑜𝑢𝑡ℎ(𝑖)
(2)
+εi 
Follow-up procedures 
To decrease the chances of Type I error, a modified Bonferroni procedure (Quene & van 
den Bergh, 2004) was conducted.  Beta weights, standard errors, effect sizes, and p values were 
examined to determine whether these variables accounted for a significant proportion of the 
variance explained within the model. 
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